Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Testare l'uso della terapia di combinazione in pazienti adulti con mieloma multiplo di nuova diagnosi, lo studio EQUATE

13 novembre 2026 aggiornato da: ECOG-ACRIN Cancer Research Group

Utilizzo efficace in quadrupla dopo la valutazione del trattamento (EQUATE): uno studio randomizzato di fase 3 per il mieloma multiplo di nuova diagnosi non destinato al trapianto autologo precoce

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

PRIMARY OBJECTIVE:

I. To determine if bortezomib, daratumumab and hyaluronidase-fihj (daratumumab), lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab and lenalidomide (DR) maintenance after standard induction therapy with daratumumab, lenalidomide and dexamethasone (DRd) results in superior overall survival compared to DRd consolidation followed by DR maintenance, in minimal residual disease (MRD) positive patients.

SECONDARY OBJECTIVES:

I. To determine if Btz-DRd consolidation followed by DR maintenance after standard induction therapy with DRd results in superior overall survival compared to DRd consolidation followed by DR maintenance in MRD negative patients.

II. To determine if Btz-DRd consolidation followed by DR maintenance after standard induction therapy with DRd results in superior progression-free survival compared to DRd consolidation followed by DR maintenance in both MRD positive and MRD negative patients.

III. To describe and compare the incidence of toxicities during consolidation between Btz-DRd and DRd arms.

IV. To assess the improvement in MRD negative rate with consolidation among patients who are MRD positive after induction.

V. To assess the sustained MRD negative rate among patients who are MRD negative after induction.

PATIENT REPORTED OUTCOMES (PRO) OBJECTIVES:

I. To quantify the extent to which the addition of bortezomib to DRd over consolidation treatment contributes to neuropathy and associated physical and functional impairments. (Primary PRO Objective) II. To evaluate the rate of resolution of neurotoxicity and associated physical and functional impairments following completion of consolidation therapy. (Secondary PRO Objective) III. To investigate the relationship between MRD status and patient reported health-related quality of life outcomes. (Exploratory PRO Objective) IV. To evaluate attributes of select patient reported treatment-emergent symptomatic adverse events (PRO- Common Terminology Criteria for Adverse Events [CTCAE]) longitudinally and compare responses with provider-reported adverse events. (Exploratory PRO Objective) V. To tabulate PRO compliance and completion rates. (Exploratory PRO Objective)

IMAGING OBJECTIVES:

I. To evaluate the association between post-induction fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) and patient outcomes (overall survival [OS] and progression-free survival [PFS]). (Primary Imaging Objective) II. To evaluate the association between baseline 18F-FDG PET/CT and patient outcomes (PFS and OS). (Secondary Imaging Objective) III. To compare overall survival with the addition of Bortezomib to consolidation DRd therapy among 18F-FDG PET/CT-positive and 18F-FDG PET/CT-negative subgroups. (Secondary Imaging Objective) IV. To evaluate the ability of baseline 18F-FDG PET/CT to predict post-induction depth of response as measured by MRD assessment. (Secondary Imaging Objective) V. To evaluate the ability of post-induction 18F-FDG PET/CT to predict MRD conversion post-consolidation. (Secondary Imaging Objective) VI. To utilize 18F-FDG PET/CT, standard risk factors and clinical data to identify distinct subgroups with differing patient outcomes (PFS and OS). (Exploratory Imaging Objective) VII. To compare the various qualitative 18F-FDG PET/CT criteria to determine which criteria yields superior risk stratification. (Exploratory Imaging Objective)

OUTLINE:

ARM A (INDUCTION): All patients receive standard induction therapy comprising the following: daratumumab subcutaneously (SC) on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide orally (PO) daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.

After completion of standard induction therapy, patients are randomized to 1 of 2 arms.

ARM B:

CONSOLIDATION: Patients receive bortezomib SC on days 1, 8, and 15, daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.

MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21 and daratumumab SC on day 1. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.

ARM C:

CONSOLIDATION: Patients receive daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.

MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21, and daratumumab SC on day 1. Cycles repeats every 28 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months if less than 2 years from study entry, every 6 months if 2-5 years from study entry, then annually for up to 15 years from study entry.

Tipo di studio

Interventistico

Iscrizione (Stimato)

1450

Fase

  • Fase 3

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Bayamón, Porto Rico, 00961
        • Sospeso
        • Puerto Rico Hematology Oncology Group
      • Bayamón, Porto Rico, 00959-5060
        • Sospeso
        • Cancer Center-Metro Medical Center Bayamon
      • Manati, Porto Rico, 00674
        • Sospeso
        • Doctors Cancer Center
      • San Juan, Porto Rico, 00917
        • Sospeso
        • San Juan Community Oncology Group
      • San Juan, Porto Rico, 00927
        • Sospeso
        • Centro Comprensivo de Cancer de UPR
      • San Juan, Porto Rico, 00936
        • Sospeso
        • San Juan City Hospital
      • San Juan, Porto Rico, 00927
        • Sospeso
        • PROncology
    • Alaska
      • Anchorage, Alaska, Stati Uniti, 98508
        • Sospeso
        • Anchorage Associates in Radiation Medicine
      • Anchorage, Alaska, Stati Uniti, 99504
        • Sospeso
        • Anchorage Radiation Therapy Center
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Alaska Breast Care and Surgery LLC
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Alaska Oncology and Hematology LLC
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Alaska Women's Cancer Care
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Anchorage Oncology Centre
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Katmai Oncology Group
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Providence Alaska Medical Center
    • Arizona
      • Phoenix, Arizona, Stati Uniti, 85004
      • Tucson, Arizona, Stati Uniti, 85704
        • Sospeso
        • University of Arizona Cancer Center-Orange Grove Campus
      • Tucson, Arizona, Stati Uniti, 85719
        • Sospeso
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, Stati Uniti, 85719
        • Sospeso
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Fort Smith, Arkansas, Stati Uniti, 72903
        • Reclutamento
        • Mercy Hospital Fort Smith
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-378-9373
        • Investigatore principale:
          • Jay W. Carlson
      • Hot Springs, Arkansas, Stati Uniti, 71913
        • Sospeso
        • CHI Saint Vincent Cancer Center Hot Springs
      • Little Rock, Arkansas, Stati Uniti, 72205
        • Reclutamento
        • CARTI Cancer Center
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Little Rock, Arkansas, Stati Uniti, 72205
        • Sospeso
        • John L McClellan Memorial Veterans Hospital
    • California
      • Arroyo Grande, California, Stati Uniti, 93420
        • Reclutamento
        • Mission Hope Medical Oncology - Arroyo Grande
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Auburn, California, Stati Uniti, 95603
        • Sospeso
        • Sutter Cancer Centers Radiation Oncology Services-Auburn
      • Auburn, California, Stati Uniti, 95602
        • Sospeso
        • Sutter Auburn Faith Hospital
      • Berkeley, California, Stati Uniti, 94704
        • Sospeso
        • Alta Bates Summit Medical Center-Herrick Campus
      • Burbank, California, Stati Uniti, 91505
        • Sospeso
        • Providence Saint Joseph Medical Center/Disney Family Cancer Center
      • Burlingame, California, Stati Uniti, 94010
        • Sospeso
        • Mills-Peninsula Medical Center
      • Cameron Park, California, Stati Uniti, 95682
        • Sospeso
        • Sutter Cancer Centers Radiation Oncology Services-Cameron Park
      • Carmichael, California, Stati Uniti, 95608
      • Carmichael, California, Stati Uniti, 95608
      • Castro Valley, California, Stati Uniti, 94546
        • Sospeso
        • Eden Hospital Medical Center
      • Davis, California, Stati Uniti, 95616
        • Sospeso
        • Sutter Davis Hospital
      • Elk Grove, California, Stati Uniti, 95758
      • Fremont, California, Stati Uniti, 94538
        • Sospeso
        • Palo Alto Medical Foundation-Fremont
      • Fremont, California, Stati Uniti, 94538
        • Reclutamento
        • Washington Health
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 510-248-1600
        • Investigatore principale:
          • Matthew E. Tenold
      • Merced, California, Stati Uniti, 95340
      • Modesto, California, Stati Uniti, 95355
        • Sospeso
        • Memorial Medical Center
      • Mountain View, California, Stati Uniti, 94040
        • Sospeso
        • Palo Alto Medical Foundation-Gynecologic Oncology
      • Mountain View, California, Stati Uniti, 94040
        • Sospeso
        • Palo Alto Medical Foundation-Camino Division
      • Novato, California, Stati Uniti, 94945
        • Sospeso
        • Sutter Cancer Research Consortium
      • Palo Alto, California, Stati Uniti, 94301
        • Sospeso
        • Palo Alto Medical Foundation Health Care
      • Rocklin, California, Stati Uniti, 95765
      • Roseville, California, Stati Uniti, 95661
        • Sospeso
        • Sutter Cancer Centers Radiation Oncology Services-Roseville
      • Roseville, California, Stati Uniti, 95661
        • Sospeso
        • Sutter Roseville Medical Center
      • Sacramento, California, Stati Uniti, 95816
      • Sacramento, California, Stati Uniti, 95816
        • Sospeso
        • Sutter Medical Center Sacramento
      • San Francisco, California, Stati Uniti, 94115
        • Sospeso
        • California Pacific Medical Center-Pacific Campus
      • San Luis Obispo, California, Stati Uniti, 93401
        • Reclutamento
        • Pacific Central Coast Health Center-San Luis Obispo
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • San Mateo, California, Stati Uniti, 94401
        • Sospeso
        • Mills Health Center
      • Santa Barbara, California, Stati Uniti, 93105
        • Sospeso
        • Ridley-Tree Cancer Center
      • Santa Cruz, California, Stati Uniti, 95065
        • Sospeso
        • Palo Alto Medical Foundation-Santa Cruz
      • Santa Cruz, California, Stati Uniti, 95065
        • Sospeso
        • Santa Cruz Radiation Oncology Medical Group
      • Santa Maria, California, Stati Uniti, 93444
        • Reclutamento
        • Mission Hope Medical Oncology - Santa Maria
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Santa Rosa, California, Stati Uniti, 95403
        • Sospeso
        • Sutter Pacific Medical Foundation
      • Stockton, California, Stati Uniti, 95204
        • Reclutamento
        • Saint Joseph's Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 209-461-5257
        • Investigatore principale:
          • Shahzad Siddique
      • Sunnyvale, California, Stati Uniti, 94086
        • Sospeso
        • Palo Alto Medical Foundation-Sunnyvale
      • Vallejo, California, Stati Uniti, 94589
        • Sospeso
        • Sutter Solano Medical Center/Cancer Center
      • Woodland, California, Stati Uniti, 95695
    • Colorado
      • Colorado Springs, Colorado, Stati Uniti, 80907
      • Colorado Springs, Colorado, Stati Uniti, 80907
      • Colorado Springs, Colorado, Stati Uniti, 80923
      • Denver, Colorado, Stati Uniti, 80210
        • Sospeso
        • AdventHealth Porter
      • Durango, Colorado, Stati Uniti, 81301
        • Sospeso
        • Mercy Medical Center
      • Durango, Colorado, Stati Uniti, 81301
        • Sospeso
        • CommonSpirit Cancer Center Mercy
      • Lakewood, Colorado, Stati Uniti, 80228
        • Reclutamento
        • CommonSpirit Saint Anthony Hospital Cancer Center
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Littleton, Colorado, Stati Uniti, 80122
        • Sospeso
        • AdventHealth Littleton
      • Longmont, Colorado, Stati Uniti, 80501
        • Sospeso
        • Longmont United Hospital
      • Longmont, Colorado, Stati Uniti, 80501
        • Sospeso
        • Rocky Mountain Cancer Centers-Longmont
      • Parker, Colorado, Stati Uniti, 80138
        • Sospeso
        • AdventHealth Parker
      • Pueblo, Colorado, Stati Uniti, 81004
      • Westminster, Colorado, Stati Uniti, 80023
    • Connecticut
      • Derby, Connecticut, Stati Uniti, 06418
        • Reclutamento
        • Smilow Cancer Hospital-Derby Care Center
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Fairfield, Connecticut, Stati Uniti, 06824
        • Reclutamento
        • Smilow Cancer Hospital Care Center-Fairfield
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Glastonbury, Connecticut, Stati Uniti, 06033
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Glastonbury
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Greenwich, Connecticut, Stati Uniti, 06830
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Greenwich
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Guilford, Connecticut, Stati Uniti, 06437
        • Reclutamento
        • Smilow Cancer Hospital Care Center - Guilford
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Hartford, Connecticut, Stati Uniti, 06105
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Saint Francis
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Hartford, Connecticut, Stati Uniti, 06102
        • Sospeso
        • Hartford Hospital
      • Meriden, Connecticut, Stati Uniti, 06451
        • Sospeso
        • Midstate Medical Center
      • New Britain, Connecticut, Stati Uniti, 06050
        • Sospeso
        • The Hospital of Central Connecticut
      • New Haven, Connecticut, Stati Uniti, 06520
        • Reclutamento
        • Yale University
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • New Haven, Connecticut, Stati Uniti, 06510
        • Reclutamento
        • Smilow Cancer Center/Yale-New Haven Hospital
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • North Haven, Connecticut, Stati Uniti, 06473
        • Reclutamento
        • Yale-New Haven Hospital North Haven Medical Center
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Orange, Connecticut, Stati Uniti, 06477
        • Reclutamento
        • Smilow Cancer Hospital-Orange Care Center
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Torrington, Connecticut, Stati Uniti, 06790
        • Reclutamento
        • Smilow Cancer Hospital-Torrington Care Center
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Trumbull, Connecticut, Stati Uniti, 06611
        • Reclutamento
        • Smilow Cancer Hospital Care Center-Trumbull
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Waterbury, Connecticut, Stati Uniti, 06708
        • Reclutamento
        • Smilow Cancer Hospital-Waterbury Care Center
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
      • Waterford, Connecticut, Stati Uniti, 06385
        • Reclutamento
        • Smilow Cancer Hospital Care Center - Waterford
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
    • Delaware
      • Lewes, Delaware, Stati Uniti, 19958
        • Attivo, non reclutante
        • Beebe Medical Center
      • Millville, Delaware, Stati Uniti, 19967
        • Attivo, non reclutante
        • Beebe South Coastal Health Campus
      • Newark, Delaware, Stati Uniti, 19713
        • Attivo, non reclutante
        • Helen F Graham Cancer Center
      • Newark, Delaware, Stati Uniti, 19713
        • Attivo, non reclutante
        • Medical Oncology Hematology Consultants PA
      • Newark, Delaware, Stati Uniti, 19713
        • Attivo, non reclutante
        • Delaware Clinical and Laboratory Physicians PA
      • Newark, Delaware, Stati Uniti, 19718
        • Attivo, non reclutante
        • Christiana Care Health System-Christiana Hospital
      • Rehoboth Beach, Delaware, Stati Uniti, 19971
        • Attivo, non reclutante
        • Beebe Health Campus
      • Seaford, Delaware, Stati Uniti, 19973
        • Sospeso
        • TidalHealth Nanticoke / Allen Cancer Center
      • Wilmington, Delaware, Stati Uniti, 19801
        • Attivo, non reclutante
        • Christiana Care Health System-Wilmington Hospital
    • District of Columbia
      • Washington D.C., District of Columbia, Stati Uniti, 20016
        • Reclutamento
        • Sibley Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Sarah Waheed
    • Florida
      • Fort Lauderdale, Florida, Stati Uniti, 33308
      • Jacksonville, Florida, Stati Uniti, 32209
        • Sospeso
        • University of Florida Health Science Center - Jacksonville
      • Pensacola, Florida, Stati Uniti, 32504
        • Sospeso
        • Sacred Heart Hospital
    • Idaho
      • Boise, Idaho, Stati Uniti, 83706
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Boise
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Boise, Idaho, Stati Uniti, 83712
        • Sospeso
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Stati Uniti, 83605
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Caldwell
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Coeur d'Alene, Idaho, Stati Uniti, 83814
        • Sospeso
        • Kootenai Health - Coeur d'Alene
      • Emmett, Idaho, Stati Uniti, 83617
        • Sospeso
        • Walter Knox Memorial Hospital
      • Fruitland, Idaho, Stati Uniti, 83619
        • Sospeso
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Stati Uniti, 83642
        • Sospeso
        • Idaho Urologic Institute-Meridian
      • Meridian, Idaho, Stati Uniti, 83642
        • Sospeso
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Stati Uniti, 83687
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Nampa
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Nampa, Idaho, Stati Uniti, 83687
        • Sospeso
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls, Idaho, Stati Uniti, 83854
        • Sospeso
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint, Idaho, Stati Uniti, 83864
        • Sospeso
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls, Idaho, Stati Uniti, 83301
        • Sospeso
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Alton, Illinois, Stati Uniti, 62002
        • Reclutamento
        • OSF Saint Anthony's Health Center
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 618-463-5623
      • Aurora, Illinois, Stati Uniti, 60506
        • Reclutamento
        • Advocate Outpatient Center - Aurora
        • Investigatore principale:
          • Thomas J. Saphner
        • Contatto:
      • Aurora, Illinois, Stati Uniti, 60504
        • Sospeso
        • Rush-Copley Medical Center
      • Barrington, Illinois, Stati Uniti, 60010
        • Reclutamento
        • Advocate Good Shepherd Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-842-4847
        • Investigatore principale:
          • Thomas J. Saphner
      • Bloomington, Illinois, Stati Uniti, 61704
        • Reclutamento
        • Illinois CancerCare-Bloomington
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Burr Ridge, Illinois, Stati Uniti, 60527
        • Sospeso
        • Loyola Center for Health at Burr Ridge
      • Canton, Illinois, Stati Uniti, 61520
        • Reclutamento
        • Illinois CancerCare-Canton
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Carbondale, Illinois, Stati Uniti, 62902
        • Reclutamento
        • Memorial Hospital of Carbondale
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Carterville, Illinois, Stati Uniti, 62918
        • Reclutamento
        • SIH Cancer Institute
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Carthage, Illinois, Stati Uniti, 62321
        • Reclutamento
        • Illinois CancerCare-Carthage
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Centralia, Illinois, Stati Uniti, 62801
        • Reclutamento
        • Centralia Oncology Clinic
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Centralia, Illinois, Stati Uniti, 62801
        • Sospeso
        • Saint Mary's Hospital
      • Chicago, Illinois, Stati Uniti, 60612
        • Attivo, non reclutante
        • University of Illinois
      • Chicago, Illinois, Stati Uniti, 60657
        • Reclutamento
        • Advocate Illinois Masonic Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 773-296-5360
        • Investigatore principale:
          • Thomas J. Saphner
      • Chicago, Illinois, Stati Uniti, 60612
        • Sospeso
        • John H Stroger Jr Hospital of Cook County
      • Chicago, Illinois, Stati Uniti, 60608
        • Sospeso
        • Mount Sinai Hospital Medical Center
      • Crystal Lake, Illinois, Stati Uniti, 60014
        • Reclutamento
        • AMG Crystal Lake - Oncology
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Danville, Illinois, Stati Uniti, 61832
        • Sospeso
        • Carle at The Riverfront
      • DeKalb, Illinois, Stati Uniti, 60115
        • Reclutamento
        • Northwestern Medicine Cancer Center Kishwaukee
        • Contatto:
        • Investigatore principale:
          • Renee Cheng
      • Decatur, Illinois, Stati Uniti, 62526
        • Reclutamento
        • Cancer Care Specialists of Illinois - Decatur
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Decatur, Illinois, Stati Uniti, 62526
        • Reclutamento
        • Decatur Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Dixon, Illinois, Stati Uniti, 61021
        • Reclutamento
        • Illinois CancerCare-Dixon
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 815-285-7800
      • Downers Grove, Illinois, Stati Uniti, 60515
        • Reclutamento
        • Advocate Good Samaritan Hospital
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Effingham, Illinois, Stati Uniti, 62401
        • Reclutamento
        • Crossroads Cancer Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Effingham, Illinois, Stati Uniti, 62401
        • Sospeso
        • Carle Physician Group-Effingham
      • Elgin, Illinois, Stati Uniti, 60123
        • Reclutamento
        • Advocate Sherman Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-429-2907
        • Investigatore principale:
          • Thomas J. Saphner
      • Eureka, Illinois, Stati Uniti, 61530
        • Reclutamento
        • Illinois CancerCare-Eureka
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Galesburg, Illinois, Stati Uniti, 61401
        • Reclutamento
        • Illinois CancerCare-Galesburg
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Galesburg, Illinois, Stati Uniti, 61401
        • Sospeso
        • Western Illinois Cancer Treatment Center
      • Geneva, Illinois, Stati Uniti, 60134
        • Reclutamento
        • Northwestern Medicine Cancer Center Delnor
        • Contatto:
        • Investigatore principale:
          • Renee Cheng
      • Hazel Crest, Illinois, Stati Uniti, 60429
        • Reclutamento
        • Advocate South Suburban Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 708-799-9995
        • Investigatore principale:
          • Thomas J. Saphner
      • Homer Glen, Illinois, Stati Uniti, 60491
        • Sospeso
        • Loyola Medicine Homer Glen
      • Kewanee, Illinois, Stati Uniti, 61443
        • Reclutamento
        • Illinois CancerCare-Kewanee Clinic
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Libertyville, Illinois, Stati Uniti, 60048
        • Reclutamento
        • AMG Libertyville - Oncology
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Libertyville, Illinois, Stati Uniti, 60048
        • Reclutamento
        • Condell Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Macomb, Illinois, Stati Uniti, 61455
        • Reclutamento
        • Illinois CancerCare-Macomb
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Mattoon, Illinois, Stati Uniti, 61938
        • Sospeso
        • Carle Physician Group-Mattoon/Charleston
      • Maywood, Illinois, Stati Uniti, 60153
        • Sospeso
        • Loyola University Medical Center
      • Melrose Park, Illinois, Stati Uniti, 60160
        • Sospeso
        • Marjorie Weinberg Cancer Center at Loyola-Gottlieb
      • Mount Vernon, Illinois, Stati Uniti, 62864
        • Reclutamento
        • SSM Health Good Samaritan
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Normal, Illinois, Stati Uniti, 61761
        • Sospeso
        • Carle Cancer Institute Normal
      • Normal, Illinois, Stati Uniti, 61761
        • Sospeso
        • Carle BroMenn Medical Center
      • O'Fallon, Illinois, Stati Uniti, 62269
        • Reclutamento
        • Cancer Care Center of O'Fallon
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • O'Fallon, Illinois, Stati Uniti, 62269
        • Reclutamento
        • HSHS Saint Elizabeth's Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Oak Lawn, Illinois, Stati Uniti, 60453-2699
        • Reclutamento
        • Advocate Christ Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-323-8622
        • Investigatore principale:
          • Thomas J. Saphner
      • Ottawa, Illinois, Stati Uniti, 61350
        • Reclutamento
        • Illinois CancerCare-Ottawa Clinic
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Park Ridge, Illinois, Stati Uniti, 60068
        • Reclutamento
        • Advocate Lutheran General Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-384-3621
        • Investigatore principale:
          • Thomas J. Saphner
      • Pekin, Illinois, Stati Uniti, 61554
        • Reclutamento
        • Illinois CancerCare-Pekin
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peoria, Illinois, Stati Uniti, 61615
        • Reclutamento
        • Illinois CancerCare-Peoria
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peoria, Illinois, Stati Uniti, 61636
        • Reclutamento
        • Methodist Medical Center of Illinois
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peru, Illinois, Stati Uniti, 61354
        • Reclutamento
        • Illinois CancerCare-Peru
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peru, Illinois, Stati Uniti, 61354
        • Reclutamento
        • Valley Radiation Oncology
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 815-664-4141
      • Princeton, Illinois, Stati Uniti, 61356
        • Reclutamento
        • Illinois CancerCare-Princeton
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Rockford, Illinois, Stati Uniti, 61114
        • Sospeso
        • UW Health Carbone Cancer Center Rockford
      • Springfield, Illinois, Stati Uniti, 62702
        • Reclutamento
        • Southern Illinois University School of Medicine
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 217-545-7929
      • Springfield, Illinois, Stati Uniti, 62702
        • Reclutamento
        • Springfield Clinic
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-444-7541
      • Springfield, Illinois, Stati Uniti, 62781
        • Reclutamento
        • Springfield Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Urbana, Illinois, Stati Uniti, 61801
        • Sospeso
        • The Carle Foundation Hospital
      • Urbana, Illinois, Stati Uniti, 61801
        • Sospeso
        • Carle Cancer Center
      • Warrenville, Illinois, Stati Uniti, 60555
        • Reclutamento
        • Northwestern Medicine Cancer Center Warrenville
        • Contatto:
        • Investigatore principale:
          • Renee Cheng
      • Washington, Illinois, Stati Uniti, 61571
        • Reclutamento
        • Illinois CancerCare - Washington
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Yorkville, Illinois, Stati Uniti, 60560
        • Sospeso
        • Rush-Copley Healthcare Center
    • Indiana
      • Carmel, Indiana, Stati Uniti, 46032
        • Non ancora reclutamento
        • IU Health North Hospital
        • Contatto:
        • Investigatore principale:
          • Rafat Abonour
      • Indianapolis, Indiana, Stati Uniti, 46202
        • Reclutamento
        • Indiana University/Melvin and Bren Simon Cancer Center
        • Contatto:
        • Investigatore principale:
          • Rafat Abonour
      • Indianapolis, Indiana, Stati Uniti, 46202
        • Non ancora reclutamento
        • IU Health Methodist Hospital
        • Contatto:
        • Investigatore principale:
          • Rafat Abonour
      • Richmond, Indiana, Stati Uniti, 47374
        • Sospeso
        • Reid Health
    • Iowa
      • Ames, Iowa, Stati Uniti, 50010
        • Reclutamento
        • Mary Greeley Medical Center
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-956-4132
      • Ames, Iowa, Stati Uniti, 50010
        • Reclutamento
        • McFarland Clinic - Ames
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
      • Ankeny, Iowa, Stati Uniti, 50023
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Boone, Iowa, Stati Uniti, 50036
        • Sospeso
        • McFarland Clinic - Boone
      • Carroll, Iowa, Stati Uniti, 51401
        • Reclutamento
        • Saint Anthony Regional Hospital
        • Contatto:
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Cedar Rapids, Iowa, Stati Uniti, 52403
        • Reclutamento
        • Mercy Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 319-365-4673
        • Investigatore principale:
          • Deborah W. Wilbur
      • Cedar Rapids, Iowa, Stati Uniti, 52403
        • Reclutamento
        • Oncology Associates at Mercy Medical Center
        • Investigatore principale:
          • Deborah W. Wilbur
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 319-363-2690
      • Clive, Iowa, Stati Uniti, 50325
        • Reclutamento
        • Mercy Cancer Center-West Lakes
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
      • Clive, Iowa, Stati Uniti, 50325
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Council Bluffs, Iowa, Stati Uniti, 51503
        • Sospeso
        • Alegent Health Mercy Hospital
      • Creston, Iowa, Stati Uniti, 50801
        • Reclutamento
        • Greater Regional Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • Broadlawns Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-282-2200
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • Mercy Medical Center - Des Moines
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
      • Des Moines, Iowa, Stati Uniti, 50309
        • Reclutamento
        • Iowa Methodist Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-6727
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50316
        • Reclutamento
        • Iowa Lutheran Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-8704
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50309
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Fort Dodge, Iowa, Stati Uniti, 50501
        • Reclutamento
        • McFarland Clinic - Trinity Cancer Center
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-956-4132
      • Fort Dodge, Iowa, Stati Uniti, 50501
        • Reclutamento
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
        • Investigatore principale:
          • Seema Harichand-Herdt
        • Contatto:
      • Jefferson, Iowa, Stati Uniti, 50129
        • Sospeso
        • McFarland Clinic - Jefferson
      • Marshalltown, Iowa, Stati Uniti, 50158
        • Reclutamento
        • McFarland Clinic - Marshalltown
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-956-4132
      • Sioux City, Iowa, Stati Uniti, 51101
        • Attivo, non reclutante
        • Siouxland Regional Cancer Center
      • Waukee, Iowa, Stati Uniti, 50263
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • West Des Moines, Iowa, Stati Uniti, 50266
        • Reclutamento
        • Mercy Medical Center-West Lakes
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
      • West Des Moines, Iowa, Stati Uniti, 50266-7700
        • Reclutamento
        • Methodist West Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-343-1000
        • Investigatore principale:
          • Seema Harichand-Herdt
    • Kansas
      • Chanute, Kansas, Stati Uniti, 66720
        • Sospeso
        • Cancer Center of Kansas - Chanute
      • Dodge City, Kansas, Stati Uniti, 67801
        • Sospeso
        • Cancer Center of Kansas - Dodge City
      • El Dorado, Kansas, Stati Uniti, 67042
        • Sospeso
        • Cancer Center of Kansas - El Dorado
      • Garden City, Kansas, Stati Uniti, 67846
        • Reclutamento
        • Central Care Cancer Center - Garden City
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Great Bend, Kansas, Stati Uniti, 67530
        • Reclutamento
        • Central Care Cancer Center - Great Bend
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Independence, Kansas, Stati Uniti, 67301
        • Sospeso
        • Cancer Center of Kansas-Independence
      • Kingman, Kansas, Stati Uniti, 67068
        • Sospeso
        • Cancer Center of Kansas-Kingman
      • Liberal, Kansas, Stati Uniti, 67905
        • Sospeso
        • Cancer Center of Kansas-Liberal
      • Manhattan, Kansas, Stati Uniti, 66502
        • Sospeso
        • Cancer Center of Kansas-Manhattan
      • McPherson, Kansas, Stati Uniti, 67460
        • Sospeso
        • Cancer Center of Kansas - McPherson
      • Newton, Kansas, Stati Uniti, 67114
        • Sospeso
        • Cancer Center of Kansas - Newton
      • Parsons, Kansas, Stati Uniti, 67357
        • Sospeso
        • Cancer Center of Kansas - Parsons
      • Pittsburg, Kansas, Stati Uniti, 66762
        • Reclutamento
        • Mercy Hospital Pittsburg
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 888-446-3729
      • Pratt, Kansas, Stati Uniti, 67124
        • Sospeso
        • Cancer Center of Kansas - Pratt
      • Salina, Kansas, Stati Uniti, 67401
        • Sospeso
        • Cancer Center of Kansas - Salina
      • Wellington, Kansas, Stati Uniti, 67152
        • Sospeso
        • Cancer Center of Kansas - Wellington
      • Wichita, Kansas, Stati Uniti, 67208
        • Sospeso
        • Cancer Center of Kansas-Wichita Medical Arts Tower
      • Wichita, Kansas, Stati Uniti, 67214
        • Sospeso
        • Ascension Via Christi Hospitals Wichita
      • Wichita, Kansas, Stati Uniti, 67214
        • Sospeso
        • Cancer Center of Kansas - Wichita
      • Winfield, Kansas, Stati Uniti, 67156
        • Sospeso
        • Cancer Center of Kansas - Winfield
    • Kentucky
      • Bardstown, Kentucky, Stati Uniti, 40004
        • Reclutamento
        • CommonSpirit Saint Joseph Hospital - Bardstown
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Corbin, Kentucky, Stati Uniti, 40701
      • Lexington, Kentucky, Stati Uniti, 40504
        • Reclutamento
        • Saint Joseph Radiation Oncology Resource Center
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Lexington, Kentucky, Stati Uniti, 40509
        • Reclutamento
        • CommonSpirit Saint Joseph Medical Center - East Lexington
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Lexington, Kentucky, Stati Uniti, 40504
        • Sospeso
        • CommonSpirit Saint Joseph Hospital - Lexington
      • London, Kentucky, Stati Uniti, 40741
      • Louisville, Kentucky, Stati Uniti, 40202
        • Sospeso
        • Jewish Hospital
      • Louisville, Kentucky, Stati Uniti, 40215
        • Sospeso
        • Saints Mary and Elizabeth Hospital
      • Louisville, Kentucky, Stati Uniti, 40245
        • Sospeso
        • UofL Health Medical Center Northeast
      • Mount Sterling, Kentucky, Stati Uniti, 40353
        • Reclutamento
        • CommonSpirit Saint Joseph Hospital Mount Sterling
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Shepherdsville, Kentucky, Stati Uniti, 40165
        • Sospeso
        • Jewish Hospital Medical Center South
    • Louisiana
      • Baton Rouge, Louisiana, Stati Uniti, 70805
        • Sospeso
        • LSU Health Baton Rouge-North Clinic
      • Baton Rouge, Louisiana, Stati Uniti, 70808
        • Sospeso
        • Our Lady of the Lake Physician Group
      • Monroe, Louisiana, Stati Uniti, 71202
        • Sospeso
        • Ochsner LSU Health Monroe Medical Center
      • Shreveport, Louisiana, Stati Uniti, 71103
        • Sospeso
        • LSU Health Sciences Center at Shreveport
    • Maryland
      • Elkton, Maryland, Stati Uniti, 21921
        • Attivo, non reclutante
        • Christiana Care - Union Hospital
      • Frederick, Maryland, Stati Uniti, 21701
        • Attivo, non reclutante
        • Frederick Memorial Hospital
      • Frederick, Maryland, Stati Uniti, 21702
        • Attivo, non reclutante
        • FMH James M Stockman Cancer Institute
    • Massachusetts
      • Boston, Massachusetts, Stati Uniti, 02111
      • Stoneham, Massachusetts, Stati Uniti, 02180
        • Reclutamento
        • Tufts Medical Center Cancer Center Stoneham
        • Investigatore principale:
          • Raymond L. Comenzo
        • Contatto:
    • Michigan
      • Adrian, Michigan, Stati Uniti, 49221
        • Sospeso
        • Hickman Cancer Center
      • Alma, Michigan, Stati Uniti, 48801
        • Reclutamento
        • MyMichigan Medical Center Gratiot
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Alpena, Michigan, Stati Uniti, 49707
        • Reclutamento
        • MyMichigan Medical Center Alpena
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Ann Arbor, Michigan, Stati Uniti, 48106
        • Reclutamento
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Battle Creek, Michigan, Stati Uniti, 49017
        • Sospeso
        • Bronson Battle Creek
      • Brighton, Michigan, Stati Uniti, 48114
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Brighton, Michigan, Stati Uniti, 48114
        • Reclutamento
        • Trinity Health Medical Center - Brighton
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Canton, Michigan, Stati Uniti, 48188
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Canton, Michigan, Stati Uniti, 48188
        • Reclutamento
        • Trinity Health Medical Center - Canton
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Caro, Michigan, Stati Uniti, 48723
        • Sospeso
        • Caro Cancer Center
      • Chelsea, Michigan, Stati Uniti, 48118
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Chelsea, Michigan, Stati Uniti, 48118
      • Clarkston, Michigan, Stati Uniti, 48346
        • Reclutamento
        • Hematology Oncology Consultants-Clarkston
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Clarkston, Michigan, Stati Uniti, 48346
        • Sospeso
        • Newland Medical Associates-Clarkston
      • Detroit, Michigan, Stati Uniti, 48202
        • Sospeso
        • Henry Ford Hospital
      • Detroit, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Health Saint John Hospital
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • East China, Michigan, Stati Uniti, 48054
        • Reclutamento
        • Henry Ford River District Hospital
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Escanaba, Michigan, Stati Uniti, 49829
        • Reclutamento
        • OSF Saint Francis Hospital and Medical Group
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Genesee Hematology Oncology PC
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Genesys Hurley Cancer Institute
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Hurley Medical Center
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Cancer Hematology Centers - Flint
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Gladwin, Michigan, Stati Uniti, 48624
        • Reclutamento
        • MyMichigan Medical Center Gladwin
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Grand Rapids, Michigan, Stati Uniti, 49503
        • Sospeso
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, Stati Uniti, 49503
        • Sospeso
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Grand Rapids, Michigan, Stati Uniti, 49503
        • Sospeso
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Grosse Pointe Woods, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Saint John Hospital - Breast
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Grosse Pointe Woods, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Saint John Hospital - Academic
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Grosse Pointe Woods, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Saint John Hospital - Van Elslander
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Kalamazoo, Michigan, Stati Uniti, 49007
        • Sospeso
        • West Michigan Cancer Center
      • Kalamazoo, Michigan, Stati Uniti, 49007
        • Sospeso
        • Bronson Methodist Hospital
      • Kalamazoo, Michigan, Stati Uniti, 49048
        • Sospeso
        • Beacon Kalamazoo
      • Kalamazoo, Michigan, Stati Uniti, 49009
        • Sospeso
        • Beacon Kalamazoo Cancer Center
      • Lansing, Michigan, Stati Uniti, 48912
        • Reclutamento
        • University of Michigan Health - Sparrow Lansing
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Livonia, Michigan, Stati Uniti, 48154
        • Sospeso
        • Hope Cancer Clinic
      • Livonia, Michigan, Stati Uniti, 48154
        • Reclutamento
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Macomb, Michigan, Stati Uniti, 48044
        • Reclutamento
        • Henry Ford Warren Hospital - Breast Macomb
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Macomb, Michigan, Stati Uniti, 48044
        • Reclutamento
        • Henry Ford Saint John Hospital - Macomb Medical
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Marlette, Michigan, Stati Uniti, 48453
        • Sospeso
        • Saint Mary's Oncology/Hematology Associates of Marlette
      • Midland, Michigan, Stati Uniti, 48670
        • Reclutamento
        • MyMichigan Medical Center Midland
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Monroe, Michigan, Stati Uniti, 48162
        • Sospeso
        • Toledo Clinic Cancer Centers-Monroe
      • Mount Pleasant, Michigan, Stati Uniti, 48858
        • Reclutamento
        • MyMichigan Medical Center Mount Pleasant
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Muskegon, Michigan, Stati Uniti, 49444
        • Sospeso
        • Trinity Health Muskegon Hospital
      • Niles, Michigan, Stati Uniti, 49120
        • Sospeso
        • Corewell Health Lakeland Hospitals - Niles Hospital
      • Norton Shores, Michigan, Stati Uniti, 49444
        • Sospeso
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
      • Novi, Michigan, Stati Uniti, 48374
        • Reclutamento
        • Henry Ford Health Providence Novi Hospital
        • Investigatore principale:
          • Adam M. Forman
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-849-5332
          • Email: kfife3@hfhs.org
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Newland Medical Associates-Pontiac
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Pontiac, Michigan, Stati Uniti, 48341
        • Sospeso
        • Hope Cancer Center
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Michigan Healthcare Professionals Pontiac
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Reed City, Michigan, Stati Uniti, 49677
        • Sospeso
        • Corewell Health Reed City Hospital
      • Rochester Hills, Michigan, Stati Uniti, 48309
        • Sospeso
        • Henry Ford Rochester Hospital
      • Saginaw, Michigan, Stati Uniti, 48604
        • Sospeso
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Stati Uniti, 48601
        • Reclutamento
        • MyMichigan Medical Center Saginaw
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Saint Joseph, Michigan, Stati Uniti, 49085
        • Sospeso
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
      • Saint Joseph, Michigan, Stati Uniti, 49085
        • Sospeso
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
      • Southfield, Michigan, Stati Uniti, 48075
        • Reclutamento
        • Henry Ford Health Providence Southfield Hospital
        • Investigatore principale:
          • Adam M. Forman
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-849-5332
          • Email: kfife3@hfhs.org
      • Sterling Heights, Michigan, Stati Uniti, 48312
        • Sospeso
        • Bhadresh Nayak MD PC-Sterling Heights
      • Tawas City, Michigan, Stati Uniti, 48764
      • Traverse City, Michigan, Stati Uniti, 49684
        • Sospeso
        • Munson Medical Center
      • Warren, Michigan, Stati Uniti, 48088
        • Sospeso
        • Advanced Breast Care Center PLLC
      • Warren, Michigan, Stati Uniti, 48093
        • Sospeso
        • Macomb Hematology Oncology PC
      • Warren, Michigan, Stati Uniti, 48093
        • Reclutamento
        • Henry Ford Madison Heights Hospital - Breast
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Warren, Michigan, Stati Uniti, 48093
        • Reclutamento
        • Henry Ford Health Warren Hospital
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • Warren, Michigan, Stati Uniti, 48093
        • Reclutamento
        • Henry Ford Warren Hospital - GLCMS
        • Investigatore principale:
          • Elie G. Dib
        • Contatto:
      • West Branch, Michigan, Stati Uniti, 48661
        • Sospeso
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Wyoming, Michigan, Stati Uniti, 49519
        • Sospeso
        • University of Michigan Health - West
      • Ypsilanti, Michigan, Stati Uniti, 48106
      • Ypsilanti, Michigan, Stati Uniti, 48197
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
    • Minnesota
      • Bemidji, Minnesota, Stati Uniti, 56601
        • Sospeso
        • Sanford Joe Lueken Cancer Center
      • Burnsville, Minnesota, Stati Uniti, 55337
        • Reclutamento
        • Minnesota Oncology - Burnsville
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Burnsville, Minnesota, Stati Uniti, 55337
        • Sospeso
        • Fairview Ridges Hospital
      • Cambridge, Minnesota, Stati Uniti, 55008
        • Reclutamento
        • Cambridge Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Chaska, Minnesota, Stati Uniti, 55318
        • Reclutamento
        • Minnesota Oncology Hematology PA-Chaska
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Coon Rapids, Minnesota, Stati Uniti, 55433
        • Reclutamento
        • Mercy Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Coon Rapids, Minnesota, Stati Uniti, 55433
        • Reclutamento
        • Minnesota Oncology - Coon Rapids
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Edina, Minnesota, Stati Uniti, 55435
        • Reclutamento
        • Fairview Southdale Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Edina, Minnesota, Stati Uniti, 55435
        • Reclutamento
        • Minnesota Oncology - Edina
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Fridley, Minnesota, Stati Uniti, 55432
        • Attivo, non reclutante
        • Unity Hospital
      • Maple Grove, Minnesota, Stati Uniti, 55369
        • Reclutamento
        • Fairview Clinics and Surgery Center Maple Grove
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Maple Grove, Minnesota, Stati Uniti, 55369
        • Reclutamento
        • Minnesota Oncology - Maple Grove
        • Investigatore principale:
          • David M. King
        • Contatto:
      • Maplewood, Minnesota, Stati Uniti, 55109
        • Reclutamento
        • Minnesota Oncology Hematology PA-Maplewood
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Maplewood, Minnesota, Stati Uniti, 55109
        • Reclutamento
        • Saint John's Hospital - Healtheast
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Minneapolis, Minnesota, Stati Uniti, 55407
        • Reclutamento
        • Abbott-Northwestern Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Minneapolis, Minnesota, Stati Uniti, 55415
        • Reclutamento
        • Hennepin County Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Minneapolis, Minnesota, Stati Uniti, 55454
        • Sospeso
        • Health Partners Inc
      • Monticello, Minnesota, Stati Uniti, 55362
        • Reclutamento
        • Monticello Cancer Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • New Ulm, Minnesota, Stati Uniti, 56073
        • Reclutamento
        • New Ulm Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Princeton, Minnesota, Stati Uniti, 55371
        • Reclutamento
        • Fairview Northland Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Robbinsdale, Minnesota, Stati Uniti, 55422
        • Reclutamento
        • North Memorial Medical Health Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Rochester, Minnesota, Stati Uniti, 55905
        • Reclutamento
        • Mayo Clinic in Rochester
        • Investigatore principale:
          • Shaji K. Kumar
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 855-776-0015
      • Saint Cloud, Minnesota, Stati Uniti, 56303
        • Sospeso
        • Coborn Cancer Center at Saint Cloud Hospital
      • Saint Louis Park, Minnesota, Stati Uniti, 55416
        • Reclutamento
        • Park Nicollet Clinic - Saint Louis Park
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Paul, Minnesota, Stati Uniti, 55101
        • Reclutamento
        • Regions Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Paul, Minnesota, Stati Uniti, 55102
        • Reclutamento
        • United Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Shakopee, Minnesota, Stati Uniti, 55379
        • Reclutamento
        • Saint Francis Regional Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Stillwater, Minnesota, Stati Uniti, 55082
        • Reclutamento
        • Lakeview Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Thief River Falls, Minnesota, Stati Uniti, 56701
        • Sospeso
        • Sanford Thief River Falls Medical Center
      • Waconia, Minnesota, Stati Uniti, 55387
        • Reclutamento
        • Ridgeview Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Willmar, Minnesota, Stati Uniti, 56201
        • Reclutamento
        • Rice Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Woodbury, Minnesota, Stati Uniti, 55125
        • Reclutamento
        • Minnesota Oncology Hematology PA-Woodbury
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Wyoming, Minnesota, Stati Uniti, 55092
        • Reclutamento
        • Fairview Lakes Medical Center
        • Contatto:
        • Investigatore principale:
          • David M. King
    • Mississippi
      • Gulfport, Mississippi, Stati Uniti, 39502
        • Reclutamento
        • Gulfport Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Augusto C. Ochoa
    • Missouri
      • Ballwin, Missouri, Stati Uniti, 63011
        • Reclutamento
        • Mercy Oncology and Hematology - Clayton-Clarkson
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 888-446-3729
      • Bolivar, Missouri, Stati Uniti, 65613
        • Reclutamento
        • Central Care Cancer Center - Bolivar
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Branson, Missouri, Stati Uniti, 65616
        • Reclutamento
        • Cox Cancer Center Branson
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 417-269-4520
      • Cape Girardeau, Missouri, Stati Uniti, 63703
        • Reclutamento
        • Saint Francis Medical Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 573-334-2230
          • Email: sfmc@sfmc.net
      • Cape Girardeau, Missouri, Stati Uniti, 63703
        • Reclutamento
        • Mercy Cancer Center - Cape Girardeau
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 888-446-3729
      • Chesterfield, Missouri, Stati Uniti, 63017
        • Sospeso
        • Saint Luke's Hospital
      • Farmington, Missouri, Stati Uniti, 63640
        • Reclutamento
        • Parkland Health Center - Farmington
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Jefferson City, Missouri, Stati Uniti, 65109
        • Sospeso
        • MU Health Care Goldschmidt Cancer Center
      • Joplin, Missouri, Stati Uniti, 64804
        • Reclutamento
        • Freeman Health System
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Joplin, Missouri, Stati Uniti, 64804
        • Reclutamento
        • Mercy Hospital Joplin
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Kansas City, Missouri, Stati Uniti, 64128
        • Reclutamento
        • Kansas City Veterans Affairs Medical Center
        • Investigatore principale:
          • Suman Kambhampati
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-525-1483
      • Osage Beach, Missouri, Stati Uniti, 65065
        • Reclutamento
        • Lake Regional Hospital
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Rolla, Missouri, Stati Uniti, 65401
        • Reclutamento
        • Mercy Clinic-Rolla-Cancer and Hematology
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 573-458-6379
      • Rolla, Missouri, Stati Uniti, 65401
        • Reclutamento
        • Phelps Health Delbert Day Cancer Institute
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Saint Joseph, Missouri, Stati Uniti, 64506
        • Reclutamento
        • Heartland Regional Medical Center
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • Sainte Genevieve, Missouri, Stati Uniti, 63670
        • Reclutamento
        • Sainte Genevieve County Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Springfield, Missouri, Stati Uniti, 65804
        • Reclutamento
        • Mercy Hospital Springfield
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 417-269-4520
      • Springfield, Missouri, Stati Uniti, 65807
        • Reclutamento
        • CoxHealth South Hospital
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 417-269-4520
      • St Louis, Missouri, Stati Uniti, 63128
        • Reclutamento
        • Mercy Hospital South
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • St Louis, Missouri, Stati Uniti, 63141
        • Reclutamento
        • Mercy Hospital Saint Louis
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-251-7066
      • St Louis, Missouri, Stati Uniti, 63131
        • Reclutamento
        • Missouri Baptist Medical Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • St Louis, Missouri, Stati Uniti, 63109
        • Reclutamento
        • Mercy Infusion Center - Chippewa
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 888-446-3729
      • Sullivan, Missouri, Stati Uniti, 63080
        • Reclutamento
        • Missouri Baptist Sullivan Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Washington, Missouri, Stati Uniti, 63090
        • Reclutamento
        • Mercy Hospital Washington
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 636-390-1600
    • Montana
      • Anaconda, Montana, Stati Uniti, 59711
        • Sospeso
        • Community Hospital of Anaconda
      • Billings, Montana, Stati Uniti, 59101
        • Sospeso
        • Billings Clinic Cancer Center
      • Bozeman, Montana, Stati Uniti, 59715
        • Sospeso
        • Bozeman Health Deaconess Hospital
      • Great Falls, Montana, Stati Uniti, 59405
        • Sospeso
        • Great Falls Clinic
      • Great Falls, Montana, Stati Uniti, 59405
        • Sospeso
        • Benefis Sletten Cancer Institute
      • Havre, Montana, Stati Uniti, 59501
        • Sospeso
        • Hi-Line Sletten Cancer Center
      • Helena, Montana, Stati Uniti, 59601
        • Sospeso
        • Benefis Helena Specialty Center
      • Kalispell, Montana, Stati Uniti, 59901
        • Sospeso
        • Logan Health Medical Center
      • Missoula, Montana, Stati Uniti, 59802
        • Reclutamento
        • Saint Patrick Hospital - Community Hospital
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Missoula, Montana, Stati Uniti, 59804
        • Sospeso
        • Community Medical Center
    • Nebraska
      • Grand Island, Nebraska, Stati Uniti, 68803
      • Grand Island, Nebraska, Stati Uniti, 68803
        • Sospeso
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Kearney, Nebraska, Stati Uniti, 68847
      • Lincoln, Nebraska, Stati Uniti, 68510
        • Sospeso
        • Saint Elizabeth Regional Medical Center
      • Lincoln, Nebraska, Stati Uniti, 68516
        • Attivo, non reclutante
        • Cancer Partners of Nebraska
      • Omaha, Nebraska, Stati Uniti, 68122
      • Omaha, Nebraska, Stati Uniti, 68124
      • Omaha, Nebraska, Stati Uniti, 68130
      • Papillion, Nebraska, Stati Uniti, 68046
        • Sospeso
        • Midlands Community Hospital
    • New Jersey
      • Cherry Hill, New Jersey, Stati Uniti, 08002
        • Reclutamento
        • Jefferson Cherry Hill Hospital
        • Contatto:
        • Investigatore principale:
          • Adam F. Binder
      • Englewood, New Jersey, Stati Uniti, 07631
        • Sospeso
        • Englewood Hospital and Medical Center
      • Morristown, New Jersey, Stati Uniti, 07960
        • Sospeso
        • Morristown Medical Center
      • Sewell, New Jersey, Stati Uniti, 08080
        • Reclutamento
        • Sidney Kimmel Cancer Center Washington Township
        • Contatto:
        • Investigatore principale:
          • Adam F. Binder
      • Summit, New Jersey, Stati Uniti, 07902
        • Sospeso
        • Overlook Hospital
    • New Mexico
      • Albuquerque, New Mexico, Stati Uniti, 87106
        • Sospeso
        • University of New Mexico Cancer Center
    • New York
      • Auburn, New York, Stati Uniti, 13021
        • Sospeso
        • Hematology Oncology Associates of Central New York-Auburn
      • Binghamton, New York, Stati Uniti, 13905
        • Sospeso
        • Lourdes Hospital
      • Camillus, New York, Stati Uniti, 13031
        • Sospeso
        • Hematology Oncology Associates of CNY at Camillus
      • East Syracuse, New York, Stati Uniti, 13057
        • Sospeso
        • Hematology Oncology Associates of Central New York-East Syracuse
      • Glens Falls, New York, Stati Uniti, 12801
        • Sospeso
        • Glens Falls Hospital
      • Rochester, New York, Stati Uniti, 14642
        • Reclutamento
        • University of Rochester
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 585-275-5830
        • Investigatore principale:
          • Brea C. Lipe
      • Stony Brook, New York, Stati Uniti, 11794
        • Attivo, non reclutante
        • Stony Brook University Medical Center
      • Syracuse, New York, Stati Uniti, 13210
        • Reclutamento
        • State University of New York Upstate Medical University
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 315-464-5476
        • Investigatore principale:
          • Krishna Ghimire
      • Verona, New York, Stati Uniti, 13478
        • Reclutamento
        • Upstate Cancer Center at Verona
        • Contatto:
        • Investigatore principale:
          • Krishna Ghimire
      • West Islip, New York, Stati Uniti, 11795
        • Attivo, non reclutante
        • Good Samaritan University Hospital
    • North Carolina
      • Clinton, North Carolina, Stati Uniti, 28328
        • Reclutamento
        • Southeastern Medical Oncology Center-Clinton
        • Contatto:
        • Investigatore principale:
          • Samer S. Kasbari
      • Goldsboro, North Carolina, Stati Uniti, 27534
        • Reclutamento
        • Southeastern Medical Oncology Center-Goldsboro
        • Contatto:
        • Investigatore principale:
          • Samer S. Kasbari
      • Greenville, North Carolina, Stati Uniti, 27834
        • Sospeso
        • East Carolina University
      • Jacksonville, North Carolina, Stati Uniti, 28546
        • Reclutamento
        • Southeastern Medical Oncology Center-Jacksonville
        • Investigatore principale:
          • Samer S. Kasbari
        • Contatto:
      • Kenansville, North Carolina, Stati Uniti, 28349
        • Attivo, non reclutante
        • ECU Health Oncology Kenansville
      • Kinston, North Carolina, Stati Uniti, 28501
        • Attivo, non reclutante
        • ECU Health Oncology Kinston
      • Richlands, North Carolina, Stati Uniti, 28574
        • Attivo, non reclutante
        • ECU Health Oncology Richlands
    • North Dakota
      • Bismarck, North Dakota, Stati Uniti, 58501
        • Sospeso
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, Stati Uniti, 58103
        • Sospeso
        • Sanford South University Medical Center
      • Fargo, North Dakota, Stati Uniti, 58103
        • Sospeso
        • Southpointe-Sanford Medical Center Fargo
      • Fargo, North Dakota, Stati Uniti, 58104
        • Sospeso
        • Sanford Medical Center Fargo
      • Fargo, North Dakota, Stati Uniti, 58122
        • Sospeso
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Stati Uniti, 58122
        • Sospeso
        • Sanford Broadway Medical Center
    • Ohio
      • Athens, Ohio, Stati Uniti, 45701
        • Reclutamento
        • OhioHealth O'Bleness Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Beachwood, Ohio, Stati Uniti, 44122
        • Attivo, non reclutante
        • UHHS-Chagrin Highlands Medical Center
      • Beavercreek, Ohio, Stati Uniti, 45431
        • Sospeso
        • Indu and Raj Soin Medical Center
      • Belpre, Ohio, Stati Uniti, 45714
        • Sospeso
        • Strecker Cancer Center-Belpre
      • Boardman, Ohio, Stati Uniti, 44512
        • Sospeso
        • Saint Elizabeth Boardman Hospital
      • Centerville, Ohio, Stati Uniti, 45459
        • Sospeso
        • Miami Valley Hospital South
      • Centerville, Ohio, Stati Uniti, 45459
        • Sospeso
        • Dayton Physicians LLC-Miami Valley South
      • Chardon, Ohio, Stati Uniti, 44024
        • Attivo, non reclutante
        • Geauga Hospital
      • Chillicothe, Ohio, Stati Uniti, 45601
        • Sospeso
        • Adena Regional Medical Center
      • Cincinnati, Ohio, Stati Uniti, 45236
        • Sospeso
        • Oncology Hematology Care Inc-Kenwood
      • Cincinnati, Ohio, Stati Uniti, 45220
      • Cincinnati, Ohio, Stati Uniti, 45242
      • Cincinnati, Ohio, Stati Uniti, 45247
      • Cincinnati, Ohio, Stati Uniti, 45255
      • Cincinnati, Ohio, Stati Uniti, 45219
        • Sospeso
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, Stati Uniti, 44109
        • Reclutamento
        • MetroHealth Medical Center
        • Contatto:
        • Investigatore principale:
          • Tamila L. Kindwall-Keller
      • Cleveland, Ohio, Stati Uniti, 44106
        • Attivo, non reclutante
        • Case Western Reserve University
      • Cleveland, Ohio, Stati Uniti, 44106
        • Sospeso
        • Louis Stokes Cleveland VA Medical Center
      • Columbus, Ohio, Stati Uniti, 43214
        • Reclutamento
        • Columbus Oncology and Hematology Associates Inc
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Columbus, Ohio, Stati Uniti, 43214
        • Reclutamento
        • Riverside Methodist Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Columbus, Ohio, Stati Uniti, 43215
        • Reclutamento
        • Grant Medical Center
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Columbus, Ohio, Stati Uniti, 43228
        • Reclutamento
        • Doctors Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Columbus, Ohio, Stati Uniti, 43213
        • Sospeso
        • Mount Carmel East Hospital
      • Columbus, Ohio, Stati Uniti, 43222
        • Sospeso
        • Mount Carmel Health Center West
      • Columbus, Ohio, Stati Uniti, 43219
        • Sospeso
        • The Mark H Zangmeister Center
      • Dayton, Ohio, Stati Uniti, 45409
        • Sospeso
        • Miami Valley Hospital
      • Dayton, Ohio, Stati Uniti, 45415
        • Sospeso
        • Miami Valley Hospital North
      • Dayton, Ohio, Stati Uniti, 45415
        • Sospeso
        • Dayton Physician LLC - Englewood
      • Dayton, Ohio, Stati Uniti, 45409
        • Sospeso
        • Premier Blood and Cancer Center
      • Delaware, Ohio, Stati Uniti, 43015
        • Reclutamento
        • Delaware Health Center-Grady Cancer Center
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Delaware, Ohio, Stati Uniti, 43015
        • Reclutamento
        • Grady Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Dublin, Ohio, Stati Uniti, 43016
        • Reclutamento
        • Columbus Oncology and Hematology Associates
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Dublin, Ohio, Stati Uniti, 43016
        • Reclutamento
        • Dublin Methodist Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Findlay, Ohio, Stati Uniti, 45840
        • Sospeso
        • Blanchard Valley Hospital
      • Findlay, Ohio, Stati Uniti, 45840
        • Sospeso
        • Orion Cancer Care
      • Findlay, Ohio, Stati Uniti, 45840
        • Sospeso
        • Armes Family Cancer Center
      • Franklin, Ohio, Stati Uniti, 45005-1066
        • Sospeso
        • Atrium Medical Center-Middletown Regional Hospital
      • Franklin, Ohio, Stati Uniti, 45005
        • Sospeso
        • Dayton Physicians LLC-Atrium
      • Gahanna, Ohio, Stati Uniti, 43230
        • Sospeso
        • Central Ohio Breast and Endocrine Surgery
      • Greenville, Ohio, Stati Uniti, 45331
        • Sospeso
        • Dayton Physicians LLC-Wayne
      • Greenville, Ohio, Stati Uniti, 45331
        • Sospeso
        • Wayne Hospital
      • Greenville, Ohio, Stati Uniti, 45331
        • Sospeso
        • Miami Valley Cancer Care and Infusion
      • Grove City, Ohio, Stati Uniti, 43123
        • Sospeso
        • Mount Carmel Grove City Hospital
      • Grove City, Ohio, Stati Uniti, 43123
        • Sospeso
        • Zangmeister Center Grove City
      • Kettering, Ohio, Stati Uniti, 45409
        • Sospeso
        • Greater Dayton Cancer Center
      • Kettering, Ohio, Stati Uniti, 45429
        • Sospeso
        • Kettering Medical Center
      • Lancaster, Ohio, Stati Uniti, 43130
        • Sospeso
        • Fairfield Medical Center
      • Lima, Ohio, Stati Uniti, 45801
        • Sospeso
        • Saint Rita's Medical Center
      • Mansfield, Ohio, Stati Uniti, 44903
        • Reclutamento
        • OhioHealth Mansfield Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Marietta, Ohio, Stati Uniti, 45750
        • Sospeso
        • Marietta Memorial Hospital
      • Marion, Ohio, Stati Uniti, 43302
        • Reclutamento
        • OhioHealth Marion General Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Marysville, Ohio, Stati Uniti, 43040
        • Sospeso
        • Memorial Hospital
      • Maumee, Ohio, Stati Uniti, 43537
        • Sospeso
        • Toledo Clinic Cancer Centers-Maumee
      • Mayfield Heights, Ohio, Stati Uniti, 44124
        • Attivo, non reclutante
        • UH Seidman Cancer Center at Landerbrook Health Center
      • Mount Vernon, Ohio, Stati Uniti, 43050
        • Sospeso
        • Knox Community Hospital
      • New Albany, Ohio, Stati Uniti, 43054
        • Sospeso
        • Mount Carmel New Albany Surgical Hospital
      • Newark, Ohio, Stati Uniti, 43055
        • Sospeso
        • Newark Radiation Oncology
      • Newark, Ohio, Stati Uniti, 43055
        • Sospeso
        • Licking Memorial Hospital
      • Parma, Ohio, Stati Uniti, 44129
        • Attivo, non reclutante
        • University Hospitals Parma Medical Center
      • Perrysburg, Ohio, Stati Uniti, 43551
        • Sospeso
        • Mercy Health - Perrysburg Hospital
      • Pickerington, Ohio, Stati Uniti, 43147
        • Reclutamento
        • OhioHealth Pickerington Methodist Hospital
        • Contatto:
        • Investigatore principale:
          • Yvonne A. Efebera
      • Portsmouth, Ohio, Stati Uniti, 45662
        • Sospeso
        • Southern Ohio Medical Center
      • Springfield, Ohio, Stati Uniti, 45504
        • Sospeso
        • Springfield Regional Cancer Center
      • Springfield, Ohio, Stati Uniti, 45504
        • Sospeso
        • Springfield Regional Medical Center
      • Toledo, Ohio, Stati Uniti, 43623
        • Sospeso
        • Mercy Health - Saint Anne Hospital
      • Toledo, Ohio, Stati Uniti, 43623
        • Sospeso
        • Toledo Clinic Cancer Centers-Toledo
      • Toledo, Ohio, Stati Uniti, 43608
        • Sospeso
        • Mercy Health - Saint Vincent Hospital
      • Toledo, Ohio, Stati Uniti, 43623
        • Sospeso
        • Mercy Health Sylvania Radiation Oncology Center
      • Troy, Ohio, Stati Uniti, 45373
        • Sospeso
        • Upper Valley Medical Center
      • Troy, Ohio, Stati Uniti, 45373
        • Sospeso
        • Dayton Physicians LLC - Troy
      • Wadsworth, Ohio, Stati Uniti, 44281
        • Attivo, non reclutante
        • University Hospitals Sharon Health Center
      • Warren, Ohio, Stati Uniti, 44484
        • Sospeso
        • Saint Joseph Warren Hospital
      • West Chester, Ohio, Stati Uniti, 45069
        • Sospeso
        • University of Cincinnati Cancer Center-West Chester
      • Westerville, Ohio, Stati Uniti, 43081
        • Sospeso
        • Saint Ann's Hospital
      • Westerville, Ohio, Stati Uniti, 43082
        • Reclutamento
        • OhioHealth Westerville Medical Campus/Westerville Cancer Center
        • Investigatore principale:
          • Yvonne A. Efebera
        • Contatto:
      • Westlake, Ohio, Stati Uniti, 44145
        • Attivo, non reclutante
        • UH Seidman Cancer Center at Saint John Medical Center
      • Wilmington, Ohio, Stati Uniti, 45177
        • Sospeso
        • Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center
      • Youngstown, Ohio, Stati Uniti, 44501
        • Sospeso
        • Saint Elizabeth Youngstown Hospital
      • Zanesville, Ohio, Stati Uniti, 43701
        • Sospeso
        • Genesis Healthcare System Cancer Care Center
    • Oklahoma
      • Oklahoma City, Oklahoma, Stati Uniti, 73120
        • Reclutamento
        • Mercy Hospital Oklahoma City
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 405-752-3402
    • Oregon
      • Baker City, Oregon, Stati Uniti, 97814
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Baker City
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Bend, Oregon, Stati Uniti, 97701
        • Sospeso
        • Saint Charles Health System
      • Clackamas, Oregon, Stati Uniti, 97015
        • Sospeso
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Stati Uniti, 97015
        • Sospeso
        • Providence Cancer Institute Clackamas Clinic
      • Coos Bay, Oregon, Stati Uniti, 97420
        • Sospeso
        • Bay Area Hospital
      • Hood River, Oregon, Stati Uniti, 97031
        • Sospeso
        • Providence Hood River Memorial Hospital
      • Newberg, Oregon, Stati Uniti, 97132
        • Sospeso
        • Providence Newberg Medical Center
      • Ontario, Oregon, Stati Uniti, 97914
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Ontario
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Oregon City, Oregon, Stati Uniti, 97045
        • Sospeso
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Stati Uniti, 97239
        • Sospeso
        • Oregon Health and Science University
      • Portland, Oregon, Stati Uniti, 97213
        • Sospeso
        • Providence Portland Medical Center
      • Portland, Oregon, Stati Uniti, 97225
        • Sospeso
        • Providence Saint Vincent Medical Center
      • Redmond, Oregon, Stati Uniti, 97756
        • Sospeso
        • Saint Charles Health System-Redmond
    • Pennsylvania
      • Allentown, Pennsylvania, Stati Uniti, 18103
        • Reclutamento
        • Lehigh Valley Hospital-Cedar Crest
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Bethlehem, Pennsylvania, Stati Uniti, 18017
        • Reclutamento
        • Lehigh Valley Hospital - Muhlenberg
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Chadds Ford, Pennsylvania, Stati Uniti, 19317
        • Attivo, non reclutante
        • Christiana Care Health System-Concord Health Center
      • Danville, Pennsylvania, Stati Uniti, 17822
        • Sospeso
        • Geisinger Medical Center
      • Dickson City, Pennsylvania, Stati Uniti, 18519
        • Sospeso
        • Geisinger Cancer Center Dickson City
      • East Stroudsburg, Pennsylvania, Stati Uniti, 18301
        • Reclutamento
        • Pocono Medical Center
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Harrisburg, Pennsylvania, Stati Uniti, 17111
        • Reclutamento
        • Penn State Health Medical Group - Andrews Patel Hematology/Oncology East
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 717-526-1030
        • Investigatore principale:
          • Shin Mineishi
      • Hazleton, Pennsylvania, Stati Uniti, 18201
        • Reclutamento
        • Lehigh Valley Hospital-Hazleton
        • Contatto:
        • Investigatore principale:
          • Elie G. Dib
      • Hazleton, Pennsylvania, Stati Uniti, 18201
        • Sospeso
        • Geisinger Medical Center-Cancer Center Hazleton
      • Hershey, Pennsylvania, Stati Uniti, 17033-0850
        • Sospeso
        • Penn State Milton S Hershey Medical Center
      • Lewisburg, Pennsylvania, Stati Uniti, 17837
        • Sospeso
        • Geisinger Medical Oncology-Lewisburg
      • Philadelphia, Pennsylvania, Stati Uniti, 19107
        • Reclutamento
        • Thomas Jefferson University Hospital
        • Contatto:
        • Investigatore principale:
          • Adam F. Binder
      • Pottsville, Pennsylvania, Stati Uniti, 17901
        • Sospeso
        • Geisinger Cancer Services-Pottsville
      • Reading, Pennsylvania, Stati Uniti, 19605
        • Sospeso
        • Penn State Health Saint Joseph Medical Center
      • Scranton, Pennsylvania, Stati Uniti, 18510
        • Sospeso
        • Community Medical Center
      • West Reading, Pennsylvania, Stati Uniti, 19611
        • Sospeso
        • Reading Hospital
      • Wilkes-Barre, Pennsylvania, Stati Uniti, 18711
        • Sospeso
        • Geisinger Wyoming Valley/Henry Cancer Center
    • Rhode Island
      • Westerly, Rhode Island, Stati Uniti, 02891
        • Reclutamento
        • Smilow Cancer Hospital Care Center - Westerly
        • Investigatore principale:
          • Sabrina Browning
        • Contatto:
    • South Carolina
      • Charleston, South Carolina, Stati Uniti, 29401
        • Reclutamento
        • Ralph H Johnson VA Medical Center
        • Contatto:
        • Investigatore principale:
          • Oleksandra Lupak
      • Charleston, South Carolina, Stati Uniti, 29425
        • Sospeso
        • Medical University of South Carolina
      • Greenville, South Carolina, Stati Uniti, 29601
        • Attivo, non reclutante
        • Saint Francis Hospital
      • Greenville, South Carolina, Stati Uniti, 29607
        • Attivo, non reclutante
        • Saint Francis Cancer Center
    • South Dakota
      • Rapid City, South Dakota, Stati Uniti, 57701
        • Reclutamento
        • Rapid City Regional Hospital
        • Investigatore principale:
          • Abdel-Ghani Azzouqa
        • Contatto:
      • Sioux Falls, South Dakota, Stati Uniti, 57105
        • Attivo, non reclutante
        • Avera Cancer Institute
    • Tennessee
      • Nashville, Tennessee, Stati Uniti, 37232
        • Sospeso
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Bryan, Texas, Stati Uniti, 77802
        • Sospeso
        • Saint Joseph Regional Cancer Center
    • Utah
      • Salt Lake City, Utah, Stati Uniti, 84112
        • Sospeso
        • Huntsman Cancer Institute/University of Utah
    • Vermont
      • Burlington, Vermont, Stati Uniti, 05401
        • Reclutamento
        • University of Vermont Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 802-656-4101
          • Email: rpo@uvm.edu
        • Investigatore principale:
          • Mansour Gergi
      • Burlington, Vermont, Stati Uniti, 05405
        • Reclutamento
        • University of Vermont and State Agricultural College
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 802-656-8990
          • Email: rpo@uvm.edu
        • Investigatore principale:
          • Mansour Gergi
      • White River Junction, Vermont, Stati Uniti, 05009
        • Reclutamento
        • White River Junction Veteran Administration Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 866-687-8387
        • Investigatore principale:
          • Britt H. Olmsted
    • Virginia
      • Charlottesville, Virginia, Stati Uniti, 22908
        • Sospeso
        • University of Virginia Cancer Center
      • Fairfax, Virginia, Stati Uniti, 22031
        • Attivo, non reclutante
        • Inova Schar Cancer Institute
      • Falls Church, Virginia, Stati Uniti, 22042
        • Attivo, non reclutante
        • Inova Fairfax Hospital
      • Lynchburg, Virginia, Stati Uniti, 24501
        • Sospeso
        • Centra Alan B Pearson Regional Cancer Center
      • Richmond, Virginia, Stati Uniti, 23229
        • Sospeso
        • Virginia Cancer Institute
      • Richmond, Virginia, Stati Uniti, 23298
        • Sospeso
        • VCU Massey Comprehensive Cancer Center
      • South Hill, Virginia, Stati Uniti, 23970
        • Sospeso
        • VCU Community Memorial Health Center
    • Washington
      • Aberdeen, Washington, Stati Uniti, 98520
        • Sospeso
        • Providence Regional Cancer System-Aberdeen
      • Bellingham, Washington, Stati Uniti, 98225
        • Sospeso
        • PeaceHealth Saint Joseph Medical Center
      • Burien, Washington, Stati Uniti, 98166
        • Sospeso
        • Highline Medical Center-Main Campus
      • Centralia, Washington, Stati Uniti, 98531
        • Sospeso
        • Providence Regional Cancer System-Centralia
      • Edmonds, Washington, Stati Uniti, 98026
        • Sospeso
        • Swedish Cancer Institute-Edmonds
      • Enumclaw, Washington, Stati Uniti, 98022
        • Sospeso
        • Saint Elizabeth Hospital
      • Everett, Washington, Stati Uniti, 98201
        • Sospeso
        • Providence Regional Cancer Partnership
      • Federal Way, Washington, Stati Uniti, 98003
        • Sospeso
        • Saint Francis Hospital
      • Issaquah, Washington, Stati Uniti, 98029
        • Sospeso
        • Swedish Cancer Institute-Issaquah
      • Kennewick, Washington, Stati Uniti, 99336
        • Sospeso
        • Kadlec Clinic Hematology and Oncology
      • Lacey, Washington, Stati Uniti, 98503
        • Sospeso
        • Providence Regional Cancer System-Lacey
      • Lakewood, Washington, Stati Uniti, 98499
        • Sospeso
        • Saint Clare Hospital
      • Longview, Washington, Stati Uniti, 98632
        • Sospeso
        • PeaceHealth Saint John Medical Center
      • Mount Vernon, Washington, Stati Uniti, 98274
        • Sospeso
        • Skagit Regional Health Cancer Care Center
      • Poulsbo, Washington, Stati Uniti, 98370
        • Attivo, non reclutante
        • Harrison HealthPartners Hematology and Oncology-Poulsbo
      • Seattle, Washington, Stati Uniti, 98104
        • Sospeso
        • Pacific Gynecology Specialists
      • Seattle, Washington, Stati Uniti, 98107
        • Sospeso
        • Swedish Medical Center-Ballard Campus
      • Seattle, Washington, Stati Uniti, 98122-5711
        • Sospeso
        • Swedish Medical Center-Cherry Hill
      • Seattle, Washington, Stati Uniti, 98122
        • Sospeso
        • Swedish Medical Center-First Hill
      • Sedro-Woolley, Washington, Stati Uniti, 98284
        • Sospeso
        • PeaceHealth United General Medical Center
      • Shelton, Washington, Stati Uniti, 98584
        • Sospeso
        • Providence Regional Cancer System-Shelton
      • Silverdale, Washington, Stati Uniti, 98383
        • Reclutamento
        • Saint Joseph Medical Center Hematology and Oncology - Silverdale
        • Investigatore principale:
          • Shahzad Siddique
        • Contatto:
      • Spokane, Washington, Stati Uniti, 99202
        • Sospeso
        • Cancer Care Northwest - Spokane South
      • Spokane, Washington, Stati Uniti, 99216
        • Sospeso
        • Cancer Care Northwest-Valley
      • Spokane, Washington, Stati Uniti, 99218
        • Sospeso
        • Cancer Care Northwest-North Spokane
      • Tacoma, Washington, Stati Uniti, 98405
        • Sospeso
        • Franciscan Research Center-Northwest Medical Plaza
      • Tacoma, Washington, Stati Uniti, 98405
        • Sospeso
        • Northwest Medical Specialties PLLC
      • Vancouver, Washington, Stati Uniti, 98664
        • Sospeso
        • PeaceHealth Southwest Medical Center
      • Walla Walla, Washington, Stati Uniti, 99362
        • Sospeso
        • Providence Saint Mary Regional Cancer Center
      • Yelm, Washington, Stati Uniti, 98597
        • Sospeso
        • Providence Regional Cancer System-Yelm
    • West Virginia
      • Charleston, West Virginia, Stati Uniti, 25304
        • Attivo, non reclutante
        • West Virginia University Charleston Division
    • Wisconsin
      • Appleton, Wisconsin, Stati Uniti, 54911
        • Reclutamento
        • ThedaCare Regional Cancer Center
        • Contatto:
        • Investigatore principale:
          • Yazhini Vallatharasu
      • Appleton, Wisconsin, Stati Uniti, 54915
        • Reclutamento
        • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Baraboo, Wisconsin, Stati Uniti, 53913
        • Attivo, non reclutante
        • SSM Health Dean Medical Group - Baraboo
      • Brookfield, Wisconsin, Stati Uniti, 53045
        • Reclutamento
        • Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Burlington, Wisconsin, Stati Uniti, 53105
        • Reclutamento
        • Aurora Cancer Care-Southern Lakes VLCC
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Chilton, Wisconsin, Stati Uniti, 53014
        • Reclutamento
        • Ascension Calumet Hospital-Chilton
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Chippewa Falls, Wisconsin, Stati Uniti, 54729
      • Cudahy, Wisconsin, Stati Uniti, 53110
        • Reclutamento
        • Aurora Saint Luke's South Shore
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Eau Claire, Wisconsin, Stati Uniti, 54701
      • Eau Claire, Wisconsin, Stati Uniti, 54701
        • Attivo, non reclutante
        • HSHS Sacred Heart Hospital
      • Franklin, Wisconsin, Stati Uniti, 53132
        • Reclutamento
        • Ascension Southeast Wisconsin Hospital - Franklin
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Franklin, Wisconsin, Stati Uniti, 53132
        • Reclutamento
        • Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Germantown, Wisconsin, Stati Uniti, 53022
        • Reclutamento
        • Aurora Health Care Germantown Health Center
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Grafton, Wisconsin, Stati Uniti, 53024
        • Reclutamento
        • Aurora Cancer Care-Grafton
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Green Bay, Wisconsin, Stati Uniti, 54311
        • Reclutamento
        • Aurora BayCare Medical Center
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Green Bay, Wisconsin, Stati Uniti, 54301
        • Reclutamento
        • Saint Vincent Hospital Cancer Center Green Bay
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Green Bay, Wisconsin, Stati Uniti, 54303
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Janesville, Wisconsin, Stati Uniti, 53546
        • Attivo, non reclutante
        • SSM Health Dean Medical Group - Janesville
      • Johnson Creek, Wisconsin, Stati Uniti, 53038
        • Sospeso
        • University of Wisconsin Carbone Cancer Center - Johnson Creek
      • Kenosha, Wisconsin, Stati Uniti, 53142
        • Reclutamento
        • Aurora Cancer Care-Kenosha South
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • La Crosse, Wisconsin, Stati Uniti, 54601
        • Reclutamento
        • Gundersen Lutheran Medical Center
        • Contatto:
        • Investigatore principale:
          • Kurt Oettel
      • La Crosse, Wisconsin, Stati Uniti, 54601
        • Sospeso
        • Mayo Clinic Health System-Franciscan Healthcare
      • Ladysmith, Wisconsin, Stati Uniti, 54848
      • Madison, Wisconsin, Stati Uniti, 53705
        • Reclutamento
        • William S Middleton VA Medical Center
        • Investigatore principale:
          • Christopher D. Fletcher
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 17007 608-256-1901
      • Madison, Wisconsin, Stati Uniti, 53792
        • Reclutamento
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • Investigatore principale:
          • Timothy M. Schmidt
        • Contatto:
      • Madison, Wisconsin, Stati Uniti, 53715
        • Attivo, non reclutante
        • SSM Health Dean Medical Group - South Madison Campus
      • Madison, Wisconsin, Stati Uniti, 53718
        • Sospeso
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
      • Marinette, Wisconsin, Stati Uniti, 54143
        • Reclutamento
        • Aurora Bay Area Medical Group-Marinette
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Marshfield, Wisconsin, Stati Uniti, 54449
      • Mequon, Wisconsin, Stati Uniti, 53097
        • Reclutamento
        • Ascension Columbia Saint Mary's Hospital-Ozaukee Campus-Mequon
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Milwaukee, Wisconsin, Stati Uniti, 53209
        • Reclutamento
        • Aurora Cancer Care-Milwaukee
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Milwaukee, Wisconsin, Stati Uniti, 53215
        • Reclutamento
        • Aurora Saint Luke's Medical Center
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Milwaukee, Wisconsin, Stati Uniti, 53233
        • Reclutamento
        • Aurora Sinai Medical Center
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Milwaukee, Wisconsin, Stati Uniti, 53211
        • Reclutamento
        • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Milwaukee, Wisconsin, Stati Uniti, 53210
        • Reclutamento
        • Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Milwaukee, Wisconsin, Stati Uniti, 53215
        • Reclutamento
        • Ascension Saint Francis Hospital-Milwaukee
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Minocqua, Wisconsin, Stati Uniti, 54548
      • Mukwonago, Wisconsin, Stati Uniti, 53149
        • Sospeso
        • ProHealth D N Greenwald Center
      • Neenah, Wisconsin, Stati Uniti, 54956
        • Reclutamento
        • ThedaCare Regional Medical Center - Neenah
        • Contatto:
        • Investigatore principale:
          • Yazhini Vallatharasu
      • Neillsville, Wisconsin, Stati Uniti, 54456
      • New Richmond, Wisconsin, Stati Uniti, 54017
        • Reclutamento
        • Cancer Center of Western Wisconsin
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Oconomowoc, Wisconsin, Stati Uniti, 53066
        • Sospeso
        • ProHealth Oconomowoc Memorial Hospital
      • Oconto Falls, Wisconsin, Stati Uniti, 54154
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Oshkosh, Wisconsin, Stati Uniti, 54904
        • Reclutamento
        • Vince Lombardi Cancer Clinic - Oshkosh
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Oshkosh, Wisconsin, Stati Uniti, 54904
        • Reclutamento
        • Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Racine, Wisconsin, Stati Uniti, 53406
        • Reclutamento
        • Aurora Cancer Care-Racine
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Racine, Wisconsin, Stati Uniti, 53405
        • Reclutamento
        • Ascension All Saints Hospital-Spring Street-Racine
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • Rice Lake, Wisconsin, Stati Uniti, 54868
      • Sheboygan, Wisconsin, Stati Uniti, 53081
        • Reclutamento
        • Vince Lombardi Cancer Clinic-Sheboygan
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Stevens Point, Wisconsin, Stati Uniti, 54482
      • Sturgeon Bay, Wisconsin, Stati Uniti, 54235-1495
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Summit, Wisconsin, Stati Uniti, 53066
        • Reclutamento
        • Aurora Medical Center in Summit
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Two Rivers, Wisconsin, Stati Uniti, 54241
        • Reclutamento
        • Vince Lombardi Cancer Clinic-Two Rivers
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Waukesha, Wisconsin, Stati Uniti, 53188
        • Sospeso
        • ProHealth Waukesha Memorial Hospital
      • Waukesha, Wisconsin, Stati Uniti, 53188
        • Sospeso
        • UW Cancer Center at ProHealth Care
      • Wausau, Wisconsin, Stati Uniti, 54401
      • Wauwatosa, Wisconsin, Stati Uniti, 53226
        • Reclutamento
        • Aurora Cancer Care-Milwaukee West
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Wauwatosa, Wisconsin, Stati Uniti, 53226
        • Reclutamento
        • Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
        • Investigatore principale:
          • Jonathan S. Treisman
        • Contatto:
      • West Allis, Wisconsin, Stati Uniti, 53227
        • Reclutamento
        • Aurora West Allis Medical Center
        • Contatto:
        • Investigatore principale:
          • Thomas J. Saphner
      • Weston, Wisconsin, Stati Uniti, 54476
      • Wisconsin Rapids, Wisconsin, Stati Uniti, 54494
    • Wyoming
      • Cheyenne, Wyoming, Stati Uniti, 82001
        • Sospeso
        • Memorial Hospital of Laramie County
      • Cody, Wyoming, Stati Uniti, 82414
        • Sospeso
        • Billings Clinic-Cody
      • Sheridan, Wyoming, Stati Uniti, 82801
        • Sospeso
        • Welch Cancer Center

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • STEP 0 - Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2 (PS 3 allowed if secondary to pain)

  • STEP 0 - Patient must have newly diagnosed multiple myeloma (MM) by International Myeloma Working Group (IMWG) criteria

  • STEP 0 - Patient must agree to register to the mandatory REVLIMID Risk Evaluation and Mitigation Strategy (RevREMS) program and be willing and able to comply with the requirements of RevREMS

  • STEP 0 - Patient must be able to undergo diagnostic bone marrow aspirate following preregistration.

    • NOTE: Bone marrow aspirate specimen must be submitted to Adaptive Biotechnologies for clonoSEQ Assay
    • NOTE: Adaptive Biotechnologies will release results to the diagnostic Portal from the Clonality (ID) test within fourteen (14) days of receipt and reconciliation of fresh bone marrow specimen to the submitting institution
  • STEP 1 - Patient must meet all eligibility criteria in STEP 0 with exception of allergy requirement

  • STEP 1 - Institution must have received the Clonality (ID) test results from Adaptive Biotechnologies and dominant sequences were identified

  • STEP 1 - Patient must have standard risk MM as defined by the Revised International Staging System (RISS) stage I or II

    • NOTE: R-ISS stage is based on serum beta2 microglobulin, albumin and lactate dehydrogenase (LDH) levels along with presence of chromosomal abnormalities (CA) detected by interphase fluorescent in situ hybridization (iFISH). Presence of del(17p), t(4;14), and/or t(14;16) is considered high risk and absence of these, including any other findings, are standard risk

    • R-ISS stage

      • Stage I: ISS stage I [beta2 macroglobulin < 3.5 mg/L, albumin > 3.5 g/dL] AND standard-risk CA AND normal LDH
      • Stage II: Not R-ISS stage I or III
      • Stage III: ISS stage III [beta2 macroglobulin > 5.5 mg/L] AND high-risk CA OR high LDH (> upper limit of normal) [patients with stage III are ineligible]
  • STEP 1 - Patient must have measurable or evaluable disease as defined by having one or more of the following, obtained within 28 days prior to registration:

    • >= 1 g/dL monoclonal protein (M-protein) on serum protein electrophoresis
    • >= 200 mg/24 hours of monoclonal protein on a 24-hour urine protein electrophoresis
    • Involved free light chain >= 10 mg/dL or >= 100 mg/L AND abnormal serum immunoglobulin kappa to lambda free light chain ratio (< 0.26 or > 1.65)
    • Monoclonal bone marrow plasmacytosis >= 30% (evaluable disease)
  • STEP 1 - Patients must have a serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), and serum free light chain (FLC) assay performed within 28 days prior to registration. In addition, a bone marrow biopsy and/or aspirate is required within 28 days if bone marrow is being followed for response

    • NOTE: UPEP (on a 24-hour collection) is required, no substitute method is acceptable. Urine must be followed monthly if the baseline urine M-spike is >= 200 mg/24 hr. Please note that if both serum and urine M-components are present, both must be followed in order to evaluate response
    • NOTE: The serum free light chain test is required to be done if the patient does not have measurable disease in the serum or urine. Measurable disease in the serum is defined as having a serum M-spike >= 1 g/dL. Measurable disease in the urine is defined as having a urine M-spike >= 200 mg/24 hr
  • STEP 1 - Calculated creatinine clearance > 30 mL/min (obtained =< 14 days prior to Step 1 registration)

  • STEP 1 - Absolute neutrophil count (ANC) >= 1000/mm^3 (obtained =< 14 days prior to Step 1 registration)

  • STEP 1 - Untransfused platelet count >= 75,000/mm^3 (obtained =< 14 days prior to Step 1 registration)

  • STEP 1 - Hemoglobin >= 8.0 g/dL (obtained =< 14 days prior to Step 1 registration)

  • STEP 1 - Total bilirubin =< 1.5 x ULN (institutional upper limit of normal) (obtained =< 14 days prior to Step 1 registration)

  • STEP 1 - Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 3 x ULN (obtained =< 14 days prior to Step 1 registration)

  • STEP 1 - Patient must have received no more than one cycle (28 days or less) of prior chemotherapy and no more than 160 mg of prior dexamethasone (or equivalent dose of prednisone) for treatment of symptomatic myeloma. Patient must not have been exposed to daratumumab for treatment of symptomatic myeloma. Prior radiation therapy to symptomatic lesions is allowed provided there are no residual toxicity related to radiation and blood counts meet the study requirements. Radiation treatment must be completed at least 14 days prior to Step 1 registration

  • STEP 1 - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization are eligible for this trial

  • STEP 1 - For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated

  • STEP 1 - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load

  • STEP 1 - Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial

  • STEP 1 - Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better. Patients must not have evidence of current uncontrolled cardiovascular conditions, including hypertension, cardiac arrhythmias, congestive heart failure, unstable angina, or myocardial infarction within 6 months prior to Step 1 registration

  • STEP 1 - Patient may have a history of current or previous deep vein thrombosis (DVT) or pulmonary embolism (PE) but must be willing to take some form of anti-coagulation as prophylaxis if they are not currently on full-dose anticoagulation

  • STEP 1 - Patients with a history of chronic obstructive pulmonary disease (COPD) must have FEV1 testing done within 28 days prior to Step 1 registration and the forced expiratory volume in 1 second (FEV1) must be > 50% of predicted normal

  • STEP 2 - Institution must have received Tracking (MRD) test results from Adaptive Biotechnologies

  • STEP 2 - Patient must have completed the Step 1 Induction phase of this protocol without experiencing progression

  • STEP 2 - Patient must be registered to Step 2 within 8 weeks of completing Step 1 Induction Treatment, counting from last day of completion of last cycle

  • STEP 2 - Patient must have an ECOG performance status (PS) of 0-2 (PS 3 allowed if secondary to pain)

  • STEP 2 - Any adverse event(s) related to Step 1 Induction Treatment must have resolved to grade 2 or less

  • STEP 2 - Hemoglobin >= 8 g/dL (obtained within 14 days prior to Step 2 randomization)

  • STEP 2 - Platelet count >= 50,000/mm^3 (obtained within 14 days prior to Step 2 randomization)

  • STEP 2 - Absolute neutrophil count (ANC) >= 1000/mm^3 (obtained within 14 days prior to Step 2 randomization)

  • STEP 2 - Calculated creatinine clearance >= 30 mL/min (obtained within 14 days prior to Step 2 randomization)

  • STEP 2 - Total bilirubin =< 1.5 x ULN (Institutional upper limit of normal) (obtained within 14 days prior to Step 2 randomization)

  • STEP 2 - ALT and AST < 3 x ULN (obtained within 14 days prior to Step 2 randomization)

Exclusion Criteria:

  • STEP 0 - Patient must not have any known allergies, hypersensitivity, or intolerance to corticosteroids, monoclonal antibodies or human proteins, or their excipients (refer to respective package inserts or Investigator's Brochure), or known sensitivity to mammalian-derived products

  • STEP 1 - Women must not be pregnant or breast-feeding due to the potential harm and teratogenic effects to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All females of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to Step 1 registration to rule out pregnancy and again within 24 hours prior to the first dose of lenalidomide. Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:

    • Has achieved menarche at some point,
    • Has not undergone a hysterectomy or bilateral oophorectomy; or
    • Has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
  • STEP 1 - Women of childbearing potential must not expect to conceive children by using accepted and effective method(s) of contraception (for this protocol defined as the use of TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting protocol treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 3 months days after the last dose of protocol treatment) OR by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception). Men must not expect to father children by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception) OR use a latex condom during sexual contact with a female of child bearing potential while participating in the study and for at least 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment

  • STEP 1 - Patient must not have peripheral neuropathy >= grade 2 on clinical examination or grade 1 with pain at time of Step 1 registration

  • STEP 1 - Patient must not have any serious medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with the completion of treatment according to this protocol

  • STEP 1 - Patient must not have moderate or severe persistent asthma within the past 2 years, or uncontrolled asthma of any classification

    • NOTE: Patients who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed to register
  • STEP 1 - Patient must not receive any other concurrent chemotherapy, or any ancillary therapy considered investigational while on this protocol

    • NOTE: Bisphosphonates are considered to be supportive care rather than therapy, and are thus allowed while on protocol treatment
  • STEP 2 - Patient must not have received any non-protocol therapy outside of the assigned Step 1 Induction treatment including stem cell transplant

  • STEP 2 - Women must not be pregnant or breast-feeding due to the potential harm and teratogenic effects to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All females of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to Step 2 randomization to rule out pregnancy and again within 24 hours prior to the first dose of lenalidomide. Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:

    • Has achieved menarche at some point,
    • Has not undergone a hysterectomy or bilateral oophorectomy; or
    • Has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
  • STEP 2 - Women of childbearing potential must not expect to conceive children by using accepted and effective method(s) of contraception (for this protocol defined as the use of TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting protocol treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 3 months days after the last dose of protocol treatment) OR by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception).

Men must not expect to father children by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence [e.g., calendar, ovulation, symptothermal, post-ovulation methods] and withdrawal are not acceptable methods of contraception) OR use a latex condom during sexual contact with a female of child bearing potential while participating in the study and for at least 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione sequenziale
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Arm A (daratumumab, lenalidomide, dexamethasone)

INDUCTION: All patients receive standard induction therapy comprising the following: daratumumab subcutaneously (SC) on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide orally (PO) daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.

Ancillary studies

Altri nomi:
  • Valutazione della qualità della vita

Given PO

Altri nomi:
  • CC-5013
  • Revimid
  • CC5013
  • CDC 501

Given PO

Altri nomi:
  • Decadrone
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba Dex
  • Alin
  • Deposito Alin
  • Alin Oftalmico
  • Ampliderma
  • Anemul mono
  • Auricolare
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decort
  • Decadrol
  • Decadrone DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluorene
  • Deronil
  • Desametasone
  • Desamoton
  • Dexa-Mamallet
  • Dexa-rinosan
  • Dexa Scheroson
  • Dexa-seno
  • Dexacortal
  • Dexacortina
  • Dexafarma
  • Dexafluorene
  • Dexalocale
  • Desamecortina
  • Dexameth
  • Desametasone Intensol
  • Dexamonozon
  • Dexapos
  • Dexinorale
  • Dexone
  • Dinormon
  • Fluorodelta
  • Fortecortina
  • Gammacorten
  • Esadecadrolo
  • Hexadrol
  • Lokalison-F
  • Loverine
  • Metilfluorprednisolone
  • Millicorten
  • Mimetasone
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazone
  • ZoDex

Given SC

Altri nomi:
  • DARA Co-formulato con rHuPH20
  • DARA/rHuPH20
  • Daratumumab + rHuPH20
  • Daratumumab con rHuPH20
  • Daratumumab-rHuPH20
  • Daratumumab/Ialuronidasi-fihj
  • Co-formulazione Daratumumab/rHuPH20
  • Darzalex Faspro
  • Darzalex/rHuPH20
  • HuMax-CD38-rHuPH20
  • Ialuronidasi umana ricombinante miscelata con Daratumumab
Sperimentale: Arm B (bortezomib, daratumumab, lenalidomide, dexamethasone)

CONSOLIDATION: Patients receive bortezomib SC on days 1, 8, and 15, daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.

MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21 and daratumumab SC on day 1. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.

Ancillary studies

Altri nomi:
  • Valutazione della qualità della vita

Given PO

Altri nomi:
  • CC-5013
  • Revimid
  • CC5013
  • CDC 501

Given PO

Altri nomi:
  • Decadrone
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba Dex
  • Alin
  • Deposito Alin
  • Alin Oftalmico
  • Ampliderma
  • Anemul mono
  • Auricolare
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decort
  • Decadrol
  • Decadrone DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluorene
  • Deronil
  • Desametasone
  • Desamoton
  • Dexa-Mamallet
  • Dexa-rinosan
  • Dexa Scheroson
  • Dexa-seno
  • Dexacortal
  • Dexacortina
  • Dexafarma
  • Dexafluorene
  • Dexalocale
  • Desamecortina
  • Dexameth
  • Desametasone Intensol
  • Dexamonozon
  • Dexapos
  • Dexinorale
  • Dexone
  • Dinormon
  • Fluorodelta
  • Fortecortina
  • Gammacorten
  • Esadecadrolo
  • Hexadrol
  • Lokalison-F
  • Loverine
  • Metilfluorprednisolone
  • Millicorten
  • Mimetasone
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazone
  • ZoDex

Given SC

Altri nomi:
  • Velcade
  • MLN341
  • PS-341
  • LDP 341
  • Acido [(1R)-3-metil-1-[[(2S)-1-osso-3-fenil-2-[(pirazinilcarbonil)ammino]propil]ammino]butil]boronico
  • PS341

Given SC

Altri nomi:
  • DARA Co-formulato con rHuPH20
  • DARA/rHuPH20
  • Daratumumab + rHuPH20
  • Daratumumab con rHuPH20
  • Daratumumab-rHuPH20
  • Daratumumab/Ialuronidasi-fihj
  • Co-formulazione Daratumumab/rHuPH20
  • Darzalex Faspro
  • Darzalex/rHuPH20
  • HuMax-CD38-rHuPH20
  • Ialuronidasi umana ricombinante miscelata con Daratumumab
Comparatore attivo: Arm C (daratumumab, lenalidomide, dexamethasone)

CONSOLIDATION: Patients receive daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity.

MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21, and daratumumab SC on day 1. Cycles repeats every 28 days in the absence of disease progression or unacceptable toxicity.

Ancillary studies

Altri nomi:
  • Valutazione della qualità della vita

Given PO

Altri nomi:
  • CC-5013
  • Revimid
  • CC5013
  • CDC 501

Given PO

Altri nomi:
  • Decadrone
  • Aacidexam
  • Adexone
  • Aknichthol Dexa
  • Alba Dex
  • Alin
  • Deposito Alin
  • Alin Oftalmico
  • Ampliderma
  • Anemul mono
  • Auricolare
  • Auxiloson
  • Baycadron
  • Baycuten
  • Baycuten N
  • Cortidexason
  • Cortisumman
  • Decort
  • Decadrol
  • Decadrone DP
  • Decalix
  • Decameth
  • Decasone R.p.
  • Dectancyl
  • Dekacort
  • Deltafluorene
  • Deronil
  • Desametasone
  • Desamoton
  • Dexa-Mamallet
  • Dexa-rinosan
  • Dexa Scheroson
  • Dexa-seno
  • Dexacortal
  • Dexacortina
  • Dexafarma
  • Dexafluorene
  • Dexalocale
  • Desamecortina
  • Dexameth
  • Desametasone Intensol
  • Dexamonozon
  • Dexapos
  • Dexinorale
  • Dexone
  • Dinormon
  • Fluorodelta
  • Fortecortina
  • Gammacorten
  • Esadecadrolo
  • Hexadrol
  • Lokalison-F
  • Loverine
  • Metilfluorprednisolone
  • Millicorten
  • Mimetasone
  • Orgadrone
  • Spersadex
  • TaperDex
  • Visumetazone
  • ZoDex

Given SC

Altri nomi:
  • DARA Co-formulato con rHuPH20
  • DARA/rHuPH20
  • Daratumumab + rHuPH20
  • Daratumumab con rHuPH20
  • Daratumumab-rHuPH20
  • Daratumumab/Ialuronidasi-fihj
  • Co-formulazione Daratumumab/rHuPH20
  • Darzalex Faspro
  • Darzalex/rHuPH20
  • HuMax-CD38-rHuPH20
  • Ialuronidasi umana ricombinante miscelata con Daratumumab

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Consolidation overall survival
Lasso di tempo: Time from Step 2 randomization at the start of consolidation to death or to the date last known alive, assessed up to 15 years

Will be estimated using the Kaplan-Meier (KM) method and compared using a stratified log-rank test. Stratified cox proportional hazards regression will produce treatment hazard ratio (bortezomib, daratumumab and hyaluronidase-fihj (daratumumab), lenalidomide and dexamethasone [Btz-DRd] then daratumumab, lenalidomide and dexamethasone [DRd] then daratumumab and lenalidomide [DR]).

Time from Step 2 randomization at the start of consolidation to death or to the date last known alive, assessed up to 15 years

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidenza di eventi avversi
Lasso di tempo: Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Incidenza di eventi avversi non ematologici di grado 3 o superiore
Lasso di tempo: Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Incidenza di eventi avversi di grado 3 o superiore
Lasso di tempo: Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Migliore risposta
Lasso di tempo: Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Durante l'induzione, il consolidamento e il mantenimento; un periodo fino a 42 mesi (9 mesi di induzione, 9 mesi di consolidamento e fino a 2 anni di mantenimento).
Consolidation progression-free survival
Lasso di tempo: Time from Step 2 randomization at the start of consolidation until the earlier of progression or death due to any cause, assessed up to 15 years

Patients alive without disease progression will be censored at date of last disease evaluation. Only deaths that occur within 3 months of the last disease evaluation are considered events.

Time from Step 2 randomization at the start of consolidation until the earlier of progression or death due to any cause, assessed up to 15 years
FACT-Ntx TOI recovery rate (Patient reported outcome [PRO])
Lasso di tempo: From end of induction through consolidation up to 1 year of maintenance, up to 21 weeks

Defined as the proportion of patients with the FACT-Ntx TOI score returning to baseline level reached at consolidation randomization after experiencing a MID decrease while on up to 1 year of maintenance.

From end of induction through consolidation up to 1 year of maintenance, up to 21 weeks

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Confronto di PRO-CTCAE selezionati con la valutazione ottenuta dal fornitore degli stessi item CTCAE (PRO)
Lasso di tempo: Fino a 15 anni
Fino a 15 anni
PRO compliance rate
Lasso di tempo: Up to 15 years

Defined as the proportion of patients who submit the given PRO instrument among those eligible at each time point which excludes those missing by design (due to death or disease progression, early treatment discontinuation).

Up to 15 years
PRO completion rate
Lasso di tempo: Up to 15 years

Defined as the proportion of patients who complete given PRO instrument based on the instrument's scoring system among those eligible at each time point.

Up to 15 years
Change in Functional Assessment of Cancer Therapy - Neurotoxicity Trial Outcome Index (FACT-Ntx TOI) score (Patient reported outcome)
Lasso di tempo: From end of induction to after completion of 9 cycles of consolidation, a period of approximately 36 weeks (9 months)

Calculated as the difference after completion of 9 cycles of consolidation therapy from end of induction. Scores can range from a minimum of 0 and a maximum of 44. A higher score on this assessment means a worse outcome.

From end of induction to after completion of 9 cycles of consolidation, a period of approximately 36 weeks (9 months)
Levels and changes of FACT-General (G) (physical well-being [PWB] + functional well-being [FWB]) score (PRO)
Lasso di tempo: From the end of induction through 1 year of maintenance, 21 weeks

The FACT-G is a single outcome measure made up of the PWB and FWB components. Scores range from a minimum of 0 and a maximum of 56. For this assessment, a higher score means a better outcome.

From the end of induction through 1 year of maintenance, 21 weeks
Presence, frequency, interference, amount and/or severity of select PRO- Common Terminology Criteria for Adverse Events (CTCAEs) (PRO)
Lasso di tempo: Up to 15 years

Presence, frequency, interference, amount and/or severity of select PRO-CTCAEs tabulated at each measurement.

Up to 15 years

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Shaji K Kumar, ECOG-ACRIN Cancer Research Group

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

24 febbraio 2021

Completamento primario (Stimato)

31 dicembre 2027

Completamento dello studio (Stimato)

31 dicembre 2027

Date di iscrizione allo studio

Primo inviato

16 settembre 2020

Primo inviato che soddisfa i criteri di controllo qualità

22 settembre 2020

Primo Inserito (Effettivo)

28 settembre 2020

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • EAA181
  • U10CA180820 (Sovvenzione/contratto NIH degli Stati Uniti)
  • EAA181 (Altro identificatore: CTEP)
  • NCI-2020-06647 (Identificatore di registro: CTRP (Clinical Trial Reporting Program))
  • EAA181 (Altro identificatore: ECOG-ACRIN Cancer Research Group)

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

Sì

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .